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Research Snapshot:  2 
Research question: In adults with or without chronic disease and/or associated risk factors, do 3 
interventions providing whole grain or whole pseudo-grain for dietary consumption improve 4 
CVD-related outcomes compared with refined grain or placebo? 5 
Key findings: This systematic review and meta-analysis found that for adults with or without 6 
CVD risk factors, consuming whole grain as opposed to refined grain may improve some 7 
cardiovascular risk factors, including total and low-density lipoprotein cholesterol, 8 
triglycerides, HbA1c, and C-reactive protein. 9 





Background: Observational data have established a link between the consumption of whole 12 
grains and reduced risk of cardiovascular disease (CVD); however, there is a need to review 13 
interventional research.  14 
Objective: In adults with or without chronic disease and/or associated risk factors, determine 15 
if interventions providing whole grain or whole pseudo-grain for dietary consumption 16 
improve CVD-related outcomes compared with refined grain or placebo.  17 
Methods: A systematic review and meta-analysis of randomized controlled trials which 18 
compared whole grain versus refined grain or placebo consumption by human adults was 19 
conducted. PubMed, CINAHL, Embase, Web of Science, and Cochrane CENTRAL were 20 
searched for studies of 12-weeks (or 2-weeks for inflammatory outcomes) duration until 21 21 
February 2020. Data were extracted for 14 types of CVD risk factors (40 outcomes in total). 22 
Risk of bias was assessed using the Cochrane Risk of Bias tool. Meta-analysis was performed 23 
using Comprehensive Meta-Analysis. GRADE was used to determine the confidence in the 24 
pooled effects and to inform a clinical recommendation. 25 
Results: 25 randomized controlled trials were included and 22 were meta-analyzed. 26 
Interventions ranged from 2- to 16-weeks; most samples were healthy (n=13 studies) and 27 
used mixed whole grains (n=11 studies). Meta-analysis found whole grain oats improved 28 
total cholesterol (SMD:-0.54[95%CI:-0.95,-0.12]) and LDL-cholesterol (SMD:-0.57[95%CI:-29 
0.84,-0.31]) whole grain rice improved triglycerides (SMD:-0.22[95%CI:-0.44,-0.01]); and 30 
whole grains (all types) improved HbA1c (SMD:-0.33[95%CI:-0.61,-0.04]) and CRP (SMD:-31 
0.22[95%CI:--0.44, -0.00]).  32 
Conclusions: For adults with or without CVD risk factors, consuming whole grains as 33 
opposed to refined grains may improve total cholesterol, LDL-cholesterol, HbA1c, and CRP. 34 




for the prevention and treatment of CVD. Further interventional research is needed to better 36 
understand the preventive and treatment potential of whole grain and whole pseudo-grain 37 
dietary intake for cardiovascular disease, particularly among those with existing CVD risk 38 





A relationship between whole grains and overall health has been well established using 41 
observational data, with cohort studies linking whole grains to reduced risk of type II diabetes 42 
mellitus (T2DM), gastrointestinal cancers, and cardiovascular disease (CVD)  1-3. Whole 43 
grains are a category of cereal foods in which the grain is intact, or where the constituents are 44 
present in proportions which represent the intact grain 4. The most common grains consumed 45 
by humans are durum wheat, oats, barley, rice, rye, sorghum, and maize/corn 5,6. In addition, 46 
pseudo-grains such as buckwheat, quinoa, and amaranth are often considered as grains due to 47 
their nutritional, culinary, and flavor profile similarities with true grains 4. The consumption 48 
of whole grains as opposed to refined grains, which contain primarily the endosperm starch, 49 
is recommended in dietary guidelines internationally 1,7,8 due to the strong nutritional profile 50 
of the bran and germ, which contain protein, dietary fiber, magnesium, potassium, selenium, 51 
zinc, iron, iodine, folate, niacin, folate, and vitamin E 9. Whole grains are also an important 52 
source of phytochemicals and antioxidants, such as phenols, flavonoids, zeaxanthin, lutein, 53 
and beta-cryptoxanthin, and provide additional health benefits, such as reduced risk of CVD, 54 
type II diabetes, and some cancers, beyond the consumption of essential nutrients 10. 55 
Cardiovascular disease is an umbrella term for a range of diseases which involve the heart 56 
and blood vessels, of which coronary heart disease (CHD), also known as ischemic heart 57 
disease, is the most common 11. Four recent systematic reviews and meta-analyses of 58 
prospective cohort studies reported that a high intake of whole grains is associated with a 19-59 
22% risk reduction in CVD and CHD incidence 12 and 15-32% risk reduction in CVD 60 
mortality 3,12-15. Dose response relationships were identified at 50g 15 and 90g 1214 for risk 61 
reduction in CVD-mortality.  Conversely, a recent systematic review and meta-analysis of 62 




controlled trials (RCTs) which measured outcomes of cardiovascular events or cardiovascular 64 
mortality.  65 
Due to the long-term diet-related etiological development of chronic disease, the incidence, 66 
and subsequent complications of CVD, such as myocardial infarctions, stroke, and death, are 67 
difficult outcomes to measure in dietary intervention studies with short durations. Therefore, 68 
dietary intervention studies have measured modifiable CVD risk factors such as blood 69 
pressure, cholesterol, or glucose intolerance. The systematic review of RCTs by Kelly et al 16 70 
found insufficient evidence for an effect of whole grains on CVD risk factors. Although the 71 
review by Kelly et al 16 was of high quality, it applied a stringent eligibility criteria on the 72 
intervention duration (≥12 weeks) which led to only nine RCTs being included. Additionally, 73 
the review only considered blood pressure and blood lipid outcomes, and other CVD risk 74 
factors including inflammatory markers, oxidative stress markers, metabolic disease 75 
incidence, glycemic and insulin markers, and other markers of hemodynamics were excluded.  76 
Therefore, in order to guide clinical practice and public health strategies, there is a need to 77 
review interventional research more broadly to determine the effect of whole grains versus 78 
refined grains on the risk of CVD and CVD-related outcomes in samples both with- and 79 
without pre-existing chronic disease. Finally, no systematic review to date has examined the 80 
effect of whole pseudo-grains on CVD-related outcomes. 81 
Research question 82 
In adults with or without chronic disease and/or associated risk factors, do interventions 83 
providing whole grain or whole pseudo-grain for dietary consumption improve 84 





Materials and methods 87 
Study design 88 
A systematic review of randomized or pseudorandomized controlled trials with a meta-89 
analysis was undertaken and reported according to the PRISMA guidelines. This study was 90 
prospectively registered at PROSPERO (CRD42019129403). 91 
Whole grains and pseudo-grains 92 
All grains and pseudo-grains were included in this review according to the international 93 
definition by the HEALTHGRAIN EU Consortium 4. Specifically, these were wheat 94 
(including spelt, emmer, einkorn, Khorasan or kamut, durums, faro), rye, oats, barley, 95 
corn/maize, rice, teff, canary seed, Job’s tears, fonio, sorghum, millet, and triticale. The 96 
included pseudo-grains were amaranth, buckwheat, quinoa, and wild rice. A food product 97 
was considered whole grain according to the HEALTHGRAIN EU Consortium definition: 98 
the intact grain or the dehulled, ground, milled, cracked or flaked grain where the 99 
constituents—endosperm, germ and bran—are present in such proportions that represent the 100 
typical ratio of those fractions occurring in the whole cereal, and includes wholemeal 4. For 101 
pseudo-grains, the same concept was applied, where a whole pseudo-grain was considered as 102 
the intact pseudo-grain or a ground, milled, cracked or flaked pseudo-grain was present with 103 
equal constituents as found in the intact pseudo-grain 4. Food products, such as bread, wraps, 104 
and breakfast cereals were considered a source of whole grain (herein referring to whole 105 
grains or whole pseudo-grains) if they contained >50% whole grain 4.  106 
Eligibility criteria 107 
Studies were deemed eligible if they were randomized controlled trials, cross-over trials, or 108 
pseudorandomized controlled trials. Other study designs such as reviews, observational 109 




eligibility criteria according to the Participant, Intervention, Comparator, and Outcome 111 
(PICO) concept. An intervention duration of ≥8-weeks was chosen to allow for diet-related 112 
changes to impact upon CVD-related risk factors; however, studies which examine 113 
inflammatory and/or oxidative stress markers have study durations starting from a ranging 114 
from a single meal to <1-month. Therefore, for outcomes related to inflammatory and/or 115 
oxidative stress markers, intervention duration ≥2-weeks was chosen to be able to review the 116 
impact of whole grains on these important CVD risk factors as this duration should allow for 117 
assessment of impact, feasibility, and safety whilst capturing a sufficient number of studies. 118 
No minimum dose was considered as part of the eligibility criteria due to the large 119 
heterogeneity in whole grain dose reporting methods across the literature. 120 
Study selection 121 
Five electronic databases were searched from database inception to 8 March 2019: Pubmed, 122 
CINAHL, Embase, Web of Science, and Cochrane CENTRAL. The search strategy (Table 2) 123 
was designed in Pubmed and translated for other databases using Polyglot 17.  Following 124 
translation, the final search algorithm for each database was checked and modified to 125 
improve sensitivity and specificity by the study authors and a librarian. The search in Pubmed 126 
was updated and searched to 21 February 2020. Grey literature and trial registries were not 127 
included as part of the search strategy. The reference lists of included studies and similar 128 
reviews were examined to identify records which the systematic strategy may have missed. 129 
Two investigators (SM, FFM) independently screened studies for eligibility via title and 130 
abstract, then full text (SM, ED) using Covidence systematic literature review software 131 
[Veritas Health Innovation, Melbourne, Australia] 18. Full-text disagreements which could 132 
not be resolved by discussion were decided by a third independent investigator (FFM). 133 




including chia seeds were excluded at the full text stage as they are not considered pseudo-135 
grains according to the HEALTHGRAIN definition 4. 136 
Outcomes and data extraction 137 
This review considered outcomes of CVD, CVD-related complications, and CVD risk factors 138 
including CVD events and symptoms, hemodynamic measures, serum plasma lipids, 139 
comorbidity incidence, inflammatory markers, oxidative stress markers, body composition, 140 
and glycemic and insulin markers. In addition, alkylresorcinol was extracted as a biomarker 141 
of whole grain intake to report intervention fidelity and adverse events were recorded. Data 142 
were extracted from publications into a Microsoft Excel [Version 1908; Excel for Office 365] 143 
spreadsheet by one investigator (SM or ED) and checked for accuracy thrice by two 144 
investigators (ED or SM). Data extracted were study and participant characteristics, baseline, 145 
follow-up, change in outcome, and p-value for between group comparisons. Where the 146 
change from baseline to follow-up was not reported it was calculated by the investigators. 147 
The data associated with this review have been published in Dryad [dataset] 19.  148 
Review of study quality and GRADE assessment 149 
Included studies were critically appraised using the Cochrane Risk of Bias tool 20 150 
independently by two investigators (SM, ED). When an outcome was pooled by meta-151 
analysis, all studies included in the meta-analysis were appraised by GRADE 21 using 152 
GRADEpro Guideline Development Tool [McMaster University, 2015, Evidence Prime, Inc] 153 
22 to determine the level of confidence in the body of evidence. The GRADE approach 154 
considers the internal validity and external validity of all studies reporting on a particular 155 
outcome so as to judge confidence in the estimated effect across the body of research 22. 156 




GRADE clinical recommendation for populations 158 
To make the clinical recommendation for populations, the findings of this study were 159 
considered in addition to other literature, stakeholder values, issues of equity, access, and 160 
feasibility, risk of benefit and harm, and other judgements made by the review investigators 161 
using GRADEpro 22. The GRADE assessment and recommendation was led by one 162 
investigator (SM), discussed and revised by a second investigator (MB); and the 163 
recommendation was discussed and agreed upon by all authors.  164 
Meta-analytical approach 165 
Outcome data for which sufficient information was reported by publications were meta-166 
analyzed by an applied statistician (PP) using Comprehensive Meta-Analysis 23. The data 167 
used in the meta-analyses were sample size (post-attrition), change in means (i.e. change 168 
from baseline to follow-up), and standard deviations (SD) in intervention and control groups 169 
that were either reported or imputed. Where SD change was not reported (most cases), it was 170 
imputed from the baseline and follow-up SDs assuming a baseline to follow-up correlation of 171 
0.7, which was derived from a rounded average of the few cases where SD change was 172 
reported. A priori moderator variables considered in the meta-analyses were: type of grain 173 
(mixed; oats; rice; wheat), health status (healthy; at risk of CVD), and study quality (high risk 174 
of bias; moderate risk of bias; low risk of bias). Other types of grains were not included as 175 
moderators as there were insufficient studies testing their efficacy. Dosage of whole grains 176 
was not included as a moderator due to large variation in the method of reporting. Values of 177 
p<0.05, or equivalently, 95% confidence intervals (CI) not crossing the null (0.0), were 178 
considered to indicate a statistically significant result. The analyses were performed both by 179 
study (combining subgroups) and then by subgroup (treating each subgroup as an 180 




The pooled outcomes were obtained as standardized mean differences (SMD, the mean 182 
difference divided by the pooled standard error from the two groups) to account for 183 
differences in measurement units and measurement techniques, and to improve 184 
generalizability of consistent (i.e. low heterogeneity) results. SMD effect sizes of <0.4 were 185 
considered small, 0.4 – 0.7 moderate, and >0.7 large 24. Where clinical interpretation of SMD 186 
was required, SMD effect sizes were re-expressed into the units by multiplying the SMD by 187 
the baseline standard deviation of one of the included studies 25. The study chosen to inform 188 
the re-expressed units was based on the highest quality study which reported variance data, 189 
with consideration of sample size. Random effects models were used for all meta-analyses.  190 
One-study-removed sensitivity analyses were obtained to determine if removing any 191 
individual study or subgroup caused significant change to the results. Analyses were then 192 
carried out using grouping by each of the moderator variables. A further sensitivity analysis 193 
was performed to determine the effect of the assumption that baseline to follow-up 194 
correlation was 0.7. For two outcome variables (HbA1c % and triglycerides) analyses were 195 
repeated using a correlation of 0.9 followed by 0.5. 196 
Bootstrapped meta-analyses were carried out using the metafor 26 and boot 27 packages in R 197 
28. Non-parametric bootstrapping was carried out using the approach described by 198 
Viechtbauer et al 2018 29 with the outcomes in which the meta-analytical models approached 199 
significance but may be subject to bias 30: HbA1c %, CRP/hCRP, and waist circumference. A 200 
variety of confidence intervals, representing different distributional assumptions, were 201 
obtained in each case. 202 





Results of the search strategy 205 
The search strategy identified 10,706 records from Pubmed, CINAHL, Embase, Web of 206 
Science, and Cochrane CENTRAL. Among these, 194 full text studies were reviewed, and 30 207 
publications were included (Figure 1). Of the 30 publications, 25 were unique RCTs. One 208 
RCT had two eligible intervention arms, leading to a total of 26 included interventions. The 209 
main reason for exclusion was “wrong intervention”, where the test product did not meet the 210 
HEALTHGRAIN EU Consortium 4 definition for whole grain, and/or the study duration did 211 
not meet the eligibility criteria. The other main reason for exclusion was ineligible 212 
comparator group, where many RCTs compared the whole grain of interest against another 213 
whole grain (e.g. oats versus wheat) or against usual diet.  214 
Study samples 215 
Of the 25 included RCTs, 13 were conducted in healthy adult populations, and 12 were in 216 
adults with CVD risk factors (Table 3). None of the studies exclusively recruited participants 217 
with existing CVD. The CVD risk factors across studies were highly diverse, and included 218 
metabolic syndrome, T2DM, hyperlipidemia, hypertension, or a combination of these. The 219 
mean age of participants ranged from 27 to 67 years, and most (16 RCTs) reported a majority 220 
of females. Across all included RCTs, there were n=1186 intervention participants and 221 
n=1109 control participants, with individual study total sample sizes ranging from n=12 to 222 
n=226 (Table 3).  The three studies Giacco et al 2013, Giacco et al 2014, and Vetrani et al 223 
2016 31-33 appeared to have some of the same participants, as did three studies reported by 224 
Kirwan et al 2016, Malin et al 2019, and Malin et al 2019 34-36, but the exact number of 225 
duplicated participants is unclear. Attrition ranged from 0% (n=7 studies) to 30%; and was 226 




(n=8), Asia (n=7), North America (n=7), the United Kingdom (n=2), and the Middle East 228 
(n=1); none were from Africa, South America, or Oceania (Table 3).  229 
Study design and quality 230 
There were 10 cross-over RCTs and 15 parallel RCTs (Table 3). Twenty-four RCTs had two-231 
arms (n=1 intervention group, n=1 control group), and one RCT had three-arms (n=2 232 
intervention group, n=1 control group).  Three RCTs were double-blinded, five were single-233 
blinded, and the remaining 17 RCTs were open-label (Table 3).  234 
Of the 25 included studies, n=7 had an intervention duration <8-weeks, which reported 235 
inflammatory and/or oxidative stress markers that were extracted as outcomes (Table 3). The 236 
remaining 18 RCTs ranged in duration from 8- to 16-weeks. To stabilize the diet prior to 237 
intervention, 11 RCTs used a run-in period, which varied from 1- to 8-weeks. The washout 238 
period of the 10 cross-over RCTs ranged from 2- to 10-weeks; however, 50% of cross-over 239 
studies did not use a washout period (Table 3). Other approaches to control the background 240 
diet were usually the recommendation or provision of isocaloric diets; however, n=5 studies 241 
prescribed hypocaloric diets to all intervention arms. Beyond hypocaloric diets, no other 242 
interventions were co-administered to both groups. 243 
Risk of bias across RCTs was generally low for detection bias, attrition bias, and reporting 244 
bias (Figure 2; justifications in Table 4). Despite all RCTs being randomized, few reported 245 
the randomization method, leading to an unclear risk of bias. Although most RCTs did not 246 
blind participants and personnel, it must be recognized this is not usually possible in dietary 247 
studies, and therefore allocation concealment would not be possible. Therefore, if an RCT 248 
had a low risk of bias on all domains except allocation concealment and blinding of 249 
participants and personnel, it was considered to have a low risk of bias. If an RCT was rated 250 




risk of bias, then it was considered to have a high risk of bias overall. There were 16 252 
publications evaluated as having low risk of bias 31,33,35,37-51 , five had a high risk of bias 52-56, 253 
and eight had an unclear risk of bias 57-63. None of the funnel plots for pooled outcomes 254 
detected evidence of publication bias. 255 
Whole grain intervention characteristics 256 
Of the 26 different interventions included, most whole grains were mixed (n=11 studies); 257 
followed by rice (n=6), wheat (n=6), oats (n=2), and barley (n=1) (Table 3). No pseudo-grain 258 
RCTs were identified which met this reviews’ eligibility criteria. The daily dose of whole 259 
grains varied widely and was reported heterogeneously. Of those that reported whole grain 260 
dose in grams per day, it ranged from 60g to 150g; except for cooked rice which ranged from 261 
150g to 400g. Where whole grains were not prescribed in a daily dose to all participants, 262 
whole grains may have been provided without a specific gram target (e.g. use in main meals 263 
twice per day) or calculated as a proportion of total daily energy or carbohydrate requirement. 264 
No RCTs used placebo as control. Whole grains were compared against their refined 265 
counterpart for most RCTs (e.g. brown rice versus white/refined rice; mixed whole grain 266 
versus mixed refined grains) (Table 3). The exceptions were Kondo et al 45 which compared 267 
mixed whole grains against refined rice, Maki et al 54 and Pins et al 61 which compared whole 268 
grain oats against mixed refined grains, and Pick et al 60 which compared whole grain barley 269 
against refined wheat. Daily doses of refined grains were rarely reported; but among those 270 
that did report them, it ranged from 60g to 150g, and 15g to 400g for cooked rice, which 271 
aligns with the range in dose of the whole grain intervention. Plasma alkylresorcinol was 272 
measured by nine RCTs; all of which reported a significantly higher level in the intervention 273 
arms (ranging from 122 to 380nmol/L) compared to control arms (ranging from 30 to 274 




The number of RCTs which reported a statistically significant improvement between groups 276 
is reported in Table 3. There were 40 outcome variables reported across all included RCTs; 277 
which could be grouped into the following outcome categories: hemodynamics (12 RCTs), 278 
body composition (15 RCTs), blood lipids (18 RCTs), glycemic and/or insulin markers (19 279 
RCTs), and inflammatory markers (21 RCTs). Only six RCTs reported oxidative stress 280 
markers, and two RCTs reported incidence of CVD comorbidities. No RCTs reported CVD 281 
and CVD-related complication outcomes.  282 
Outcomes of whole grains compared to refined grains reported by included studies 283 
Of the 40 outcomes measured across all RCTs, 23 (58%) were found to have one or more 284 
RCT report a statistically significant improvement in the whole grain intervention compared 285 
to refined grain comparator. For six outcomes (15%), a significant difference between groups 286 
was reported to favor whole grain in some studies and refined grain in others; and one 287 
outcome (fat free mass) was reported to favor refined grain alone (Table 5). Blood lipids had 288 
the largest number of studies that reported beneficial effects of whole grains compared to 289 
refined grains (11 RCTs); however, they also had the largest number of RCTs that reported 290 
results favoring refined grains (5 RCTs).  291 
Most publications did not report on adverse events. Four studies reported minor 292 
gastrointestinal symptoms, with low incidence varying from 2-16% which was comparable 293 
between intervention and control arms 49,54,57,61. There was also one case of faintness reported 294 
in the intervention group 41 and one case of gastroenteritis in the control group 54. 295 
Pooled effects of whole grains compared to refined grains on cardiovascular disease risk 296 
factors 297 
There were 20 RCTs (across 22 publications) included to meta-analyze 14 outcomes (Table 298 




subgroup (e.g. males and females separately); leading to 23 intervention groups included in 300 
the models. A further sensitivity analysis was carried out to evaluate the effect of the 301 
assumption that baseline to follow-up correlation was 0.7. For the two variables HbA1c% and 302 
triglycerides, analyses repeated using correlation of first 0.9 and then 0.5 led to no 303 
appreciable difference in results.  304 
In initial models, which ranged between 9-18 RCTs (or RCT subgroups) per outcome, we 305 
were unable to reject the null hypothesis for any pooled effect; sensitivity analysis did not 306 
indicate any change. Confidence that the pooled estimated effect reflects the true effect 307 
ranged from very low to moderate (Table 6; justifications in Table 7); the most common 308 
reason for decreased confidence was due to risk of bias in individual studies, statistical 309 
heterogeneity, and some imprecision.  310 
Subgroup analysis by type of grain found that whole grain oats significantly decreased total 311 
cholesterol (SMD: -0.54 [95%CI: -0.95, -0.12] re-expressed as -20.8mg/dL [-0.54mmol/L], 312 
p=0.011, n=232 [IG: 122, CG: 110], I2: 56.9%,  GRADE level of evidence: very low; Figure 313 
3) and LDL cholesterol (SMD: -0.57 [95%CI: -0.84, -0.31] re-expressed as -16.7mg/dL [-314 
0.43mmol/L], p<0.0001, n=232 [IG: 122, CG: 110], I2: 0%; GRADE level of evidence: very 315 
low; Figure 4) compared to refined grains. Standard deviations of baseline total and LDL 316 
cholesterol in the intervention group reported by Pins et al. 61 was used to re-express SMD to 317 
mg/dL for clinical interpretation. Compared to white rice, brown rice decreased triglycerides 318 
(SMD: -0.22 [95%CI: -0.44, -0.01] re-expressed as -1.6mg/dL [-0.02mmol/L], p=0.040, 319 
n=338 [IG: 171, CG: 167], I2: 0%, GRADE level of evidence: very low). The triglyceride 320 
standard deviation from the intervention group in Araki et al 49 was used to re-express SMD 321 
to mg/dL. 322 
Subgroup analysis found that mixed whole grains decreased (i.e. negative direction) HDL 323 




expressed as -2.0mg/dL [-0.06 mmol/L], p=0.037, n=590 (IG: 292, CG: 298), I2: 0%, 325 
GRADE level of evidence: high). However, in moderate quality studies (i.e. unclear risk of 326 
bias), whole grains improved HDL cholesterol (SMD: 0.33 [95%CI: 0.05, 0.62] re-expressed 327 
as 3mg/dL [0.08mmol/L], p=0.022, n=490 (IG: 255, CG: 235), I2: 5.1%,  GRADE level of 328 
evidence: low) compared to refined grains. To re-express HDL cholesterol SMDs into a 329 
clinically interpretable value, standard deviations from Giacco et al 2013 32 and Pins et al 61 330 
were used respectively. 331 
Further subgroup analysis by study quality found that in higher quality studies (i.e. low risk 332 
of bias), whole grains improved CRP (SMD: -0.22 [95%CI: -0.44, -0.00] re-expressed as -333 
0.7mg/L, p=0.048, n=671 (intervention group (IG): 311, comparator group (CG): 360), I2: 334 
45.7%, GRADE level of evidence: moderate); and decreased HbA1c (SMD: -0.33 [95%CI: -335 
0.61, -0.04] re-expressed as -0.2%, p=0.025, n=194 (IG: 97, CG: 97), I2: 0%, GRADE level 336 
of evidence: moderate). CRP and HbA1c standard deviation from the intervention group 337 
reported Kirwan et al 34 was used to re-express the CRP and HbA1c SMD for clinical 338 
interpretation. No other subgroup analyses found significant findings; however, study 339 
samples which had CVD risk factors approach a significant decrease in triglycerides (SMD: -340 
0.13 [95%CI: -0.23, 0.03], p=0.065, n=10 studies).  341 
The non-parametric bootstrapped meta-analyses were HbA1c SMD: -0.27 (95%CI: -0.44, 342 
0.39), for CRP/hs-CRP SMD: -0.25 (95%CI: -0.45, 0.25), and waist circumference SMD: -343 
0.10 (95%CI: -0.21, 0.08).  344 
Discussion 345 
The benefits of consuming whole grains to human health is well established, due to their 346 
nutrient and antioxidant profile and strong association with improved chronic disease 347 




response relationship for decreased risk of CVD-related death reported by meta-analyses of 349 
observational data 12,14; the current review of RCTs found insufficient evidence to conclude 350 
that dietary intake of whole grains has a clinically relevant effect on CVD risk factors in 351 
comparison to refined grains. Although this review’s meta-analytical models found some 352 
improvements in triglycerides, HbA1c, and CRP, there was very low to moderate confidence 353 
in the body of evidence, and the re-expressed effect sizes have no clinical significance. 354 
Whole grain oats had clinically relevant improvements on LDL and total cholesterol, aligning 355 
with other literature 64, but had very low confidence that this estimated effect represented the 356 
true effect.  357 
Unexpectedly, there was high confidence that mixed whole grains had a small (re-expressed 358 
as -2.0mg/dL) but significant decrease in cardioprotective HDL cholesterol compared to 359 
refined grains.  HDL cholesterol is predominately regulated through hepatic synthesis and 360 
cholesterol ester transfer protein (CETP) activity, which replaces cholesterol esters in HDL 361 
particles with triglycerides. Triglyceride-rich HDL particles are substrates for hepatic lipase, 362 
which promotes HDL cholesterol clearance 65. There was no effect of mixed grains on 363 
triglyceride levels, suggesting that an effect on CETP activity does not explain the observed 364 
difference in HDL-cholesterol. Most mixed grain studies used wheat, rye, rice, and/or oats, 365 
while two studies included barley. However, neither oats, rice, nor wheat showed 366 
independent effects on HDL-cholesterol in the meta-analysis and are thus unlikely to explain 367 
this effect. Conversely, the subgroup by study design meta-analysis found that studies with an 368 
unclear risk of bias, which represented RCTs using mixed, rice, barley, and wheat test 369 
products, significantly increased HDL cholesterol with a similar effect size (3mg/dL). 370 
However, this finding should be rejected as relevant in the light that the positive estimated 371 
effect had a low confidence and the studies with low risk of bias found no significant effect. 372 




The present findings align with those reported by Kelly et al. 16, who reviewed nine whole 374 
grain RCTs with durations ≥12-weeks, in that the included studies have inherent limitations, 375 
and findings may be subject to change with additional research. This is particularly the case 376 
among those with existing CVD, as the study populations in this review were predominantly 377 
healthy or had only mild-to-moderate CVD risk factors.  Having relatively healthy samples 378 
may explain both the finding of no overall pooled effect of whole grains compared to refined 379 
grains on CVD risk factors, as well as the finding that some subgroup improvement CVD risk 380 
factors were of statistical but not clinical significance. For example, it is unlikely that an 381 
improvement in CRP, SBP, or HbA1C would occur among those who do not have elevated 382 
CRP, SBP, or HbA1C at baseline. Similarly, the systematic review and meta-analysis by 383 
Hollander et al 66, which evaluated the effect of whole grains on blood lipids in healthy 384 
populations only, found no significant pooled effects of whole grains, except for the beta-385 
glucan containing subgroups. Although some studies measured adherence to the allocated 386 
groups objectively through plasma alkylresorcinol, many RCTs did not measure adherence to 387 
the intervention and/or control and dietary intake could have possibly been too low to detect a 388 
significant change in CVD risk factors. Interpretation of findings is substantially limited by 389 
the poor reporting of whole grain daily dose; where dosages of both intervention and test 390 
products is not able to be determined. Few studies reported whole grain intake as dose per 391 
day as recommended by Ross et al. 67 Other limitations include poorly reported dosage of 392 
refined grains, inadequately controlled and/or measured background diet, and the possibility 393 
of underpowered models due to the small number of included studies in each model, 394 
particularly in subgroups.  395 
Differences between meta-analyses of RCTs and prospective cohort studies on whole grain 396 
and CVD must also be acknowledged. Pooled data from prospective cohort studies is derived 397 




grains for many years, and sometimes decades 12,14; and the potential for whole grains to have 399 
a preventive and/or treatment effect is increased. This contrasts with the identified 400 
interventional research, which is limited by study duration ranging between 2- to 16-weeks. 401 
Recalling that diet-related etiologies of chronic disease have long latency periods; it is 402 
difficult to detect significant effects in a short timeframe. Considering some subgroups found 403 
significant improvements in inflammation, glycemia, and blood lipids, it is possible that with 404 
an increased intervention duration and investigations targeted at those with elevated risk 405 
factors, improvements in CVD incidence and death may be observed.  Additional research is 406 
required to confirm this hypothesis. The importance of intervention duration is emphasized 407 
by the types of outcomes measured in prospective cohort studies, which include CVD-related 408 
death and events, including myocardial infarctions and strokes 12,14. This is in contrast with 409 
RCTs which are limited to measuring CVD risk markers, and thus, indirect CVD outcomes.  410 
Despite attempts to control for confounding variables in observational data, the improved 411 
CVD outcomes in the meta-analyses of observational data may represent the effects of 412 
broader dietary and lifestyle patterns. Participants in cohort studies who reported consuming 413 
whole grains as opposed to refined grains may be those who adhere to a healthier lifestyle; 414 
and over many years this lifestyle presents multiple confounding factors which are inherently 415 
difficult to measure and account for 68. The finding that some refined grain arms of RCTs had 416 
higher attrition than the whole grain arms also suggests that low whole grain consumers in 417 
observational studies may not necessarily be high refined grain consumers. In observational 418 
research, it is possible that low whole grain consumers replace whole grains with 419 
discretionary foods rather than refined grain core foods, thereby creating a greater 420 
discrepancy in the diet quality of the two groups, leading to a greater observed effect size in 421 
high whole grain consumers. It must be remembered that grains are recommended by dietary 422 




mostly as whole grains and/or higher fiber varieties, refined grains are not considered 424 
discretionary foods 1,7,8. 425 
Of clinical significance, the RCTs in this review reported that participants either had equal or 426 
lower attrition in the whole grain group, as well as a high compliance to the whole grain 427 
intervention when measured by plasma alkylresorcinol. This suggests that dietary intake of 428 
whole grains is a feasible dietary strategy in culturally diverse populations and strengthens 429 
the need to test other types of grains that are important to certain cultural groups in RCTs.  430 
GRADE clinical recommendation for populations 431 
A conditional recommendation was made for the intervention: For adults with or without CVD 432 
risk factors, the findings of this review conditionally recommend whole grains for improved 433 
CVD risk based on very weak to moderate evidence. In line with the GRADE approach, this 434 
conditional recommendation is subject to change with new evidence.  435 
This recommendation was based on the balance of beneficial effects, which tended towards 436 
the intervention and is strengthened by observational and economic research (Table 8)  437 
12,14,15,69. However, due to inherent limitations and risk of bias found in the interventional 438 
research, even when drawing upon other research, a strong recommendation cannot yet be 439 
made. There is no uncertainty that prevention cardiovascular disease is valued by all 440 
stakeholders and is feasible to implement considering grains being a staple food to many 441 
cultures and countries, and dietary guidelines already recommending that grains should be 442 
consumed as a whole grain. Healthy food basket research suggests that whole grain foods 443 
may be unavailable to some small communities and may be associated with a higher cost, 444 
which is likely to impact upon low income families 70 (Table 8). 445 
Limitations of this review  446 
Whilst eligibility criteria included 40 broad outcomes related to CVD risk, outcomes such as 447 




review. The review was not able to evaluate the effect of whole grains on CVD outcome; and 449 
it should be highlighted that all outcomes reported are indirect measures of CVD risk only. It 450 
was beyond the scope of this review to examine a dose-response relationship through meta-451 
regression. Finally, although funnel plots did not detect publication bias, this may have been 452 
due to the small number of included studies in each model.  453 
Implications for future research 454 
The effect of whole grain intake on CVD is of high interest to both the individual and to 455 
governments, as CVD is the leading cause of noncommunicable disease deaths worldwide 71. 456 
Future RCTs are required which compare whole grain versus refined grain for all grain and 457 
pseudo grain varieties, especially rye, maize, teff, amaranth, triticale, or unique varieties of 458 
wheat such as kamut or spelt. Future RCTs need to be well-powered and use parallel design 459 
so as to allow for substantially longer intervention durations; such as that used in 460 
PREDIMED 72. Additionally, whole grain products should be tested for the potential to 461 
improve both CVD risk factors and events in samples with existing CVD at baseline. Studies 462 
should control and/or measure background diet and medications carefully, so the effect of the 463 
whole grain as opposed to other diet and lifestyle factors can be understood. The dosage of 464 
whole grain intake should be reported in grams per day as recommended by Ross et al. 67 465 
Finally, CVD related outcomes should be accompanied by feasibility evaluations to better 466 





For adults with or without CVD risk factors, consuming whole grain as opposed to refined 469 
grain may improve total cholesterol, LDL-cholesterol, HbA1c, and CRP. However, there is 470 
insufficient interventional evidence to recommend the use of whole grains as opposed to 471 
refined grains for the prevention and treatment of CVD. Further interventional research is 472 
needed to better understand the preventive and treatment potential of whole grain and whole 473 
pseudo-grain dietary intake for cardiovascular disease, particularly among those with existing 474 
CVD risk factors. 475 
 476 
Figure Legends 477 
Figure 2: Risk of bias summary: a review of investigators’ judgements about each risk of 478 
bias item for all included randomized controlled trials, as guided by the Cochrane risk of bias 479 
tool 20which compared whole grain or whole pseudo-grain interventions and placebo or 480 
refined grain controls in humans. 481 
 482 
Figure 3: Whole grain oats compared with refined mixed grains had a significant effect on 483 
total cholesterol (SMD: -0.54 [95%CI: -0.95, -0.12], I2: 56.9%, p=0.011) when pooling 484 
results of two randomized controlled trials during subgroup analysis by grain type. 485 
 486 
Figure 4: Whole grain oats compared with mixed refined grains had a significant effect on 487 
LDL cholesterol (SMD: -0.57 [95%CI: -0.84, -0.31], p<0.0001, n=232 [IG: 122, CG: 110], 488 
I2: 0%)  when pooling results of two randomized controlled trials during subgroup analysis 489 
by grain type.490 
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Practice implications:  
What is the current knowledge on the topic? Whole grains have a higher nutrient density than 
refined grains; and observational studies have identified an association between whole grain 
intake and improved cardiovascular disease risk. 
How does this research add to knowledge on this topic? This systematic review of 
randomised controlled trials examines the cause-and-effect relationship between whole grain 
intake and cardiovascular disease risk. 
How might this knowledge impact current dietetics practice? Choosing whole grains is 
recommended for populations to improve cardiovascular disease risk but evidence is not 
convincing enough to use whole grains as a cardiovascular disease treatment approach. 
 
Online Supplementary Material 1 
The effect of replacing refined grains with whole grains on cardiovascular risk factors:  A systematic review and meta-analysis of 
randomized controlled trials with GRADE clinical recommendation 
 
Figure S1: Whole grains compared with refined grains has no significant effect on CRP/hs-CRP (SMD: -0.11 [95%CI: -0.47, 0.25], I2: 88.9%, 
p=0.542). 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Ampatzoglou 2016 -0.38 0.25 0.121
Andersson 2007 0.45 0.26 0.084
Giacco 2013 -0.26 0.18 0.159
Harris Jackson 2014 0.00 0.28 1.000
Kazemzadeh 2014 per1 -0.10 0.24 0.682
Kazemzadeh 2014 per2 -0.14 0.24 0.557
Kirwan 2016 0.50 0.25 0.047
Kondo 2017 -0.70 0.39 0.073
Kristensen 2012 -0.12 0.24 0.601
Kristensen 2017 0.13 0.15 0.400
Roager 2019 -0.50 0.20 0.014
Schutte 2018 -0.59 0.29 0.041
Shimabukuro 2014 per1 0.55 0.28 0.047
Shimabukuro 2014 per2 1.42 0.30 0.000
Tighe 2010 -1.85 0.20 0.000
Fixed -0.17 0.06 0.006
Random -0.11 0.18 0.542
-3.00 -1.50 0.00 1.50 3.00
Favours Intervention Favours Control
CRP and hsCRP
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The effect of replacing refined grains with whole grains on cardiovascular risk factors:  A systematic review and meta-analysis of 




Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
A Ampatzoglou 2016 -0.38 0.25 0.121
A Giacco 2013 -0.26 0.18 0.159
A Harris Jackson 2014 0.00 0.28 1.000
A Kazemzadeh 2014 per1 -0.10 0.24 0.682
A Kazemzadeh 2014 per2 -0.14 0.24 0.557
A Kirwan 2016 0.50 0.25 0.047
A Kondo 2017 -0.70 0.39 0.073
A Roager 2019 -0.50 0.20 0.014
A Schutte 2018 -0.59 0.29 0.041
A -0.22 0.11 0.048
B Andersson 2007 0.45 0.26 0.084
B Kristensen 2012 -0.12 0.24 0.601
B Tighe 2010 -1.85 0.20 0.000
B -0.51 0.72 0.475
C Kristensen 2017 0.13 0.15 0.400
C Shimabukuro 2014 per1 0.55 0.28 0.047
C Shimabukuro 2014 per2 1.42 0.30 0.000
C 0.67 0.38 0.076
Overall -0.16 0.11 0.140
-3.00 -1.50 0.00 1.50 3.00
Favours Intervention Favours Control
CRP and hsCRP
Online Supplementary Material 1 
The effect of replacing refined grains with whole grains on cardiovascular risk factors:  A systematic review and meta-analysis of 
randomized controlled trials with GRADE clinical recommendation 
Figure S2: Whole grains compared with refined grains has a significant effect on CRP/hs-CRP (SMD: -0.22 [95%CI: -0.44, -0.00, p=0.048, I2: 
45.7%) for the high quality study subgroup only (A, high quality; B, unclear quality; C, low quality). 
 
Figure S3: Whole grains compared with refined grains has no significant effect on IL-6 (SMD: -0.08 [95%CI: -0.29, 0.13], I2: 51.0%, p=0.450). 
 
 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Ampatzoglou 2016 -0.22 0.25 0.372
Andersson 2007 0.02 0.26 0.938
Giacco 2013 0.14 0.18 0.447
Harris Jackson 2014 0.20 0.28 0.481
Kristensen 2012 0.07 0.24 0.757
Roager 2019 -0.77 0.21 0.000
Tighe 2010 0.14 0.17 0.409
Vanegas 2017 -0.14 0.22 0.540
Vitaglione 2015 -0.13 0.24 0.584
Fixed -0.07 0.07 0.323
Random -0.08 0.11 0.457
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
IL-6
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Figure S4: Whole grains compared with refined grains has no significant effect on fasting plasma glucose (SMD: -0.01 [95%CI: -0.19, 0.16], I2: 
60.4%, p=0.875). 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 0.46 0.33 0.164
Giacco 2013 0.25 0.18 0.172
Giacco 2014 0.20 0.27 0.469
Harris Jackson 2014 -0.60 0.29 0.038
Kazemzadeh 2014 per1 0.03 0.24 0.893
Kikuchi 2018 0.09 0.29 0.742
Kirwan 2016 -0.39 0.25 0.114
Kondo 2017 -0.43 0.38 0.263
Kristensen 2012 0.13 0.24 0.578
Kristensen 2017 -0.05 0.15 0.759
Pins 2002 -0.61 0.22 0.005
Roager 2019 -0.22 0.20 0.269
Schutte 2018 0.26 0.28 0.355
Tighe 2010 -0.30 0.17 0.080
Vitaglione 2015 0.85 0.25 0.001
Zhang 2011 0.14 0.14 0.344
Fixed -0.02 0.05 0.761
Random -0.01 0.09 0.875
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
Fasting plasma glucose
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Figure S5: Whole grains compared with refined grains has no significant effect on fasting plasma insulin (SMD: 0.07 [95%CI: -0.05, 0.18], I2: 
0%, p=0.265). 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Giacco 2013 0.25 0.18 0.169
Giacco 2014 -0.00 0.27 0.998
Harris Jackson 2014 0.06 0.28 0.840
Kikuchi 2018 -0.32 0.29 0.267
Kirwan 2016 0.09 0.25 0.717
Kondo 2017 -0.14 0.38 0.718
Kristensen 2012 0.00 0.24 1.000
Kristensen 2017 0.12 0.15 0.441
Roager 2019 -0.03 0.20 0.864
Schutte 2018 -0.07 0.28 0.802
Tighe 2010 0.31 0.17 0.075
Vitaglione 2015 0.06 0.24 0.796
Zhang 2011 -0.01 0.14 0.920
Fixed 0.07 0.06 0.265
Random 0.07 0.06 0.265
-1.00 -0.50 0.00 0.50 1.00
Favours Intervention Favours Control
Fasting plasma insulin
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Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 0.07 0.33 0.840
Giacco 2014 0.14 0.27 0.603
Harris Jackson 2014 0.00 0.28 1.000
Kirwan 2016 -0.08 0.25 0.741
Kondo 2017 -0.15 0.38 0.691
Kristensen 2012 0.12 0.24 0.602
Roager 2019 0.00 0.20 1.000
Schutte 2018 -0.11 0.28 0.704
Shimabukuro 2014 per1 -0.27 0.27 0.320
Shimabukuro 2014 per2 -0.11 0.27 0.679
Tighe 2010 -0.10 0.17 0.563
Zhang 2011 -0.00 0.14 0.973
Fixed -0.03 0.07 0.603
Random -0.03 0.07 0.603
-1.00 -0.50 0.00 0.50 1.00
Favours Intervention Favours Control
HOMA-IR
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Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 0.00 0.33 1.000
Kirwan 2016 -0.21 0.25 0.403
Kondo 2017 -0.24 0.38 0.534
Kristensen 2012 0.00 0.24 1.000
Kristensen 2017 0.11 0.15 0.486
Nakayama 2017 -2.58 0.46 0.000
Roager 2019 -0.43 0.20 0.033
Shimabukuro 2014 per1 -0.20 0.27 0.470
Shimabukuro 2014 per2 0.33 0.27 0.228
Zhang 2011 -0.11 0.14 0.449
Fixed -0.13 0.07 0.059
Random -0.24 0.15 0.122
-4.00 -2.00 0.00 2.00 4.00
Favours Intervention Favours Control
HbA1c%
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Figure S8: Whole grains compared with refined grains has a significant effect on HbA1c (SMD: -0.33 [95%CI: -0.61, -0.04] %, I2: 0%, p=0.025) 




Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
A Kirwan 2016 -0.21 0.25 0.403
A Kondo 2017 -0.24 0.38 0.534
A Roager 2019 -0.43 0.20 0.033
A -0.33 0.14 0.025
B Kristensen 2012 0.00 0.24 1.000
B Zhang 2011 -0.11 0.14 0.449
B -0.08 0.12 0.518
C Araki 2017 0.00 0.33 1.000
C Kristensen 2017 0.11 0.15 0.486
C Nakayama 2017 -2.58 0.46 0.000
C Shimabukuro 2014 per1 -0.20 0.27 0.470
C Shimabukuro 2014 per2 0.33 0.27 0.228
C -0.38 0.35 0.279
Overall -0.20 0.09 0.031
-4.00 -2.00 0.00 2.00 4.00
Favours Intervention Favours Control
HbA1c%
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Figure S9: Whole grains compared with refined grains has no significant effect on total cholesterol (SMD: -0.10 [95%CI: -0.29, 0.09] mmol/L, I2: 
67.3%, p=0.291). 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 0.31 0.33 0.352
Giacco 2013 0.09 0.18 0.623
Kikuchi 2018 -0.18 0.29 0.530
Kirwan 2016 -0.23 0.25 0.349
Kondo 2017 -0.42 0.38 0.269
Kristensen 2012 -0.38 0.24 0.113
Kristensen 2017 -0.08 0.15 0.621
Maki 2010 -0.35 0.17 0.039
Pins 2002 -0.77 0.22 0.000
Roager 2019 -0.27 0.20 0.177
Schutte 2018 0.00 0.28 1.000
Shimabukuro 2014 per1 -0.77 0.28 0.006
Shimabukuro 2014 per2 0.58 0.28 0.036
Tighe 2010 0.47 0.17 0.006
Vitaglione 2015 -0.09 0.24 0.696
Zhang 2011 0.27 0.14 0.067
Fixed -0.07 0.05 0.213
Random -0.10 0.10 0.291
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
Total cholesterol
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Figure S10: Whole grains compared with refined grains has no significant effect on HDL-cholesterol (SMD: -0.01 [95%CI: -0.15, 0.13], I2: 
38.7%, p=0.896). 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 0.70 0.34 0.038
Giacco 2013 -0.07 0.18 0.681
Giacco 2014 -0.19 0.27 0.491
Harris Jackson 2014 -0.60 0.29 0.038
Kikuchi 2018 men 0.50 0.29 0.083
Kikuchi 2018 women -0.04 0.49 0.934
Kirwan 2016 -0.18 0.25 0.454
Kondo 2017 -0.38 0.38 0.314
Kristensen 2012 -0.15 0.24 0.535
Kristensen 2017 -0.18 0.15 0.238
Pins 2002 0.29 0.21 0.182
Roager 2019 0.00 0.20 1.000
Schutte 2018 0.00 0.28 1.000
Shimabukuro 2014 per1 -0.46 0.28 0.093
Shimabukuro 2014 per2 -0.06 0.27 0.832
Tighe 2010 0.18 0.17 0.304
Vitaglione 2015 -0.15 0.24 0.533
Zhang 2011 0.33 0.14 0.022
Fixed 0.01 0.05 0.887
Random -0.01 0.07 0.896
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours Intervention
HDL cholesterol
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Figure S11: Mixed whole grains compared with refined grains has decreases HDL cholesterol (SMD: -0.17 [95%CI: -0.33, -0.01], I2: 0%, p=0.037) 
for the high quality study subgroup only (A, high quality; B, unclear quality; C, low quality). 
Group by
Grain
Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
mixed Giacco 2013 -0.07 0.18 0.681
mixed Giacco 2014 -0.19 0.27 0.491
mixed Harris Jackson 2014 -0.60 0.29 0.038
mixed Kirwan 2016 -0.18 0.25 0.454
mixed Kondo 2017 -0.38 0.38 0.314
mixed Kristensen 2017 -0.18 0.15 0.238
mixed Roager 2019 0.00 0.20 1.000
mixed -0.17 0.08 0.037
oats Pins 2002 0.29 0.21 0.182
oats 0.29 0.21 0.182
rice Araki 2017 0.70 0.34 0.038
rice Shimabukuro 2014 per1 -0.46 0.28 0.093
rice Shimabukuro 2014 per2 -0.06 0.27 0.832
rice Zhang 2011 0.33 0.14 0.022
rice 0.12 0.22 0.576
wheat Kikuchi 2018 men 0.50 0.29 0.083
wheat Kikuchi 2018 women -0.04 0.49 0.934
wheat Kristensen 2012 -0.15 0.24 0.535
wheat Schutte 2018 0.00 0.28 1.000
wheat Tighe 2010 0.18 0.17 0.304
wheat Vitaglione 2015 -0.15 0.24 0.533
wheat 0.07 0.10 0.503
Overall -0.03 0.06 0.556
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours Intervention
HDL cholesterol
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Figure S12: Whole grains compared with refined grains increases HDL cholesterol (SMD: 0.21 [95%CI: 0.02, 0.39], I2: 5.1%, p=0.027) for the 
Group by
Quality
Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
A Giacco 2013 -0.07 0.18 0.681
A Giacco 2014 -0.19 0.27 0.491
A Harris Jackson 2014 -0.60 0.29 0.038
A Kikuchi 2018 men 0.50 0.29 0.083
A Kikuchi 2018 women -0.04 0.49 0.934
A Kirwan 2016 -0.18 0.25 0.454
A Kondo 2017 -0.38 0.38 0.314
A Roager 2019 0.00 0.20 1.000
A Schutte 2018 0.00 0.28 1.000
A Vitaglione 2015 -0.15 0.24 0.533
A -0.10 0.08 0.239
B Kristensen 2012 -0.15 0.24 0.535
B Pins 2002 0.29 0.21 0.182
B Tighe 2010 0.18 0.17 0.304
B Zhang 2011 0.33 0.14 0.022
B 0.21 0.09 0.027
C Araki 2017 0.70 0.34 0.038
C Kristensen 2017 -0.18 0.15 0.238
C Shimabukuro 2014 per1 -0.46 0.28 0.093
C Shimabukuro 2014 per2 -0.06 0.27 0.832
C -0.05 0.20 0.807
Overall 0.03 0.06 0.638
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours Intervention
HDL cholesterol
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unclear quality study subgroup only (A, high quality; B, unclear quality; C, low quality). 
 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 0.34 0.33 0.300
Giacco 2013 0.07 0.18 0.693
Giacco 2014 -0.04 0.27 0.886
Harris Jackson 2014 0.06 0.28 0.819
Kikuchi 2018 0.02 0.29 0.938
Kirwan 2016 -0.22 0.25 0.377
Kondo 2017 -0.26 0.38 0.488
Kristensen 2012 -0.33 0.24 0.165
Kristensen 2017 -0.04 0.15 0.807
Maki 2010 -0.50 0.17 0.003
Pins 2002 -0.71 0.22 0.001
Roager 2019 0.00 0.20 1.000
Shimabukuro 2014 per1 -0.63 0.28 0.025
Shimabukuro 2014 per2 0.32 0.27 0.250
Tighe 2010 0.30 0.17 0.078
Zhang 2011 0.33 0.14 0.025
Fixed -0.05 0.05 0.365
Random -0.07 0.09 0.405
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
LDL cholesterol
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Figure S13: Whole grains compared with refined grains has no significant effect on LDL cholesterol (SMD: -0.07 [95%CI: -0.25, 0.10], I2: 59.6%, 
p=0.405). 
 
Figure S14: Whole grains compared with refined grains has no significant effect on triglycerides (SMD: -0.06 [95%CI: -0.21, 0.10], I2: 49.9%, 
p=0.477). 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 -0.63 0.34 0.061
Giacco 2013 0.06 0.18 0.756
Giacco 2014 0.03 0.27 0.906
Harris Jackson 2014 0.33 0.28 0.242
Kikuchi 2018 -0.65 0.29 0.027
Kirwan 2016 -0.02 0.25 0.932
Kristensen 2012 -0.04 0.24 0.868
Kristensen 2017 0.03 0.15 0.866
Pins 2002 -0.16 0.21 0.448
Roager 2019 -0.18 0.20 0.357
Schutte 2018 -0.44 0.29 0.123
Shimabukuro 2014 per1 -0.06 0.27 0.812
Shimabukuro 2014 per2 -0.35 0.27 0.197
Tighe 2010 0.64 0.18 0.000
Vitaglione 2015 0.15 0.24 0.547
Zhang 2011 -0.16 0.14 0.271
Fixed -0.03 0.05 0.570
Random -0.06 0.08 0.477
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
Triglycerides
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Figure S15: Whole grain rice compared with refined rice decreased triglycerides (SMD: -0.22 [95%CI: -0.44, -0.01], I2: 0%, p=0.040). 
Group by
Grain
Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
mixed Giacco 2013 0.06 0.18 0.756
mixed Giacco 2014 0.03 0.27 0.906
mixed Harris Jackson 2014 0.33 0.28 0.242
mixed Kirwan 2016 -0.02 0.25 0.932
mixed Kristensen 2017 0.03 0.15 0.866
mixed Roager 2019 -0.18 0.20 0.357
mixed 0.02 0.08 0.838
oats Pins 2002 -0.16 0.21 0.448
oats -0.16 0.21 0.448
rice Araki 2017 -0.63 0.34 0.061
rice Shimabukuro 2014 per1 -0.06 0.27 0.812
rice Shimabukuro 2014 per2 -0.35 0.27 0.197
rice Zhang 2011 -0.16 0.14 0.271
rice -0.22 0.11 0.040
wheat Kikuchi 2018 -0.65 0.29 0.027
wheat Kristensen 2012 -0.04 0.24 0.868
wheat Schutte 2018 -0.44 0.29 0.123
wheat Tighe 2010 0.64 0.18 0.000
wheat Vitaglione 2015 0.15 0.24 0.547
wheat -0.04 0.24 0.874
Overall -0.08 0.06 0.205
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
Triglycerides
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Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Giacco 2013 0.00 0.18 1.000
Harris Jackson 2014 1.05 0.30 0.000
Kikuchi 2018 0.24 0.29 0.395
Kondo 2017 0.14 0.38 0.705
Kristensen 2012 0.37 0.24 0.117
Kristensen 2017 0.08 0.15 0.591
Pins 2002 -0.71 0.22 0.001
Roager 2019 -0.22 0.20 0.269
Shimabukuro 2014 per1 -0.55 0.28 0.048
Shimabukuro 2014 per2 -0.55 0.28 0.046
Zhang 2011 -0.06 0.14 0.681
Fixed -0.05 0.06 0.451
Random -0.04 0.13 0.781
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
Systolic blood pressure
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Figure S17: Whole grains compared with refined grains has no significant effect on diastolic blood pressure (SMD: 0.05 [95%CI: -0.26, 0.37], I2: 
83.1%, p=0.730). 
 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Giacco 2013 0.15 0.18 0.416
Harris Jackson 2014 2.50 0.38 0.000
Kikuchi 2018 0.10 0.29 0.728
Kirwan 2016 -0.18 0.25 0.473
Kondo 2017 -0.35 0.38 0.354
Kristensen 2012 0.14 0.24 0.549
Kristensen 2017 0.15 0.15 0.333
Pins 2002 -0.91 0.22 0.000
Roager 2019 -0.09 0.20 0.662
Shimabukuro 2014 per1 -0.24 0.27 0.387
Shimabukuro 2014 per2 -0.16 0.27 0.568
Zhang 2011 -0.02 0.14 0.915
Fixed 0.00 0.06 0.978
Random 0.05 0.16 0.730
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
Diastolic blood pressure
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Figure S18: Whole grains compared with refined grains has no significant effect on total body weight (SMD: -0.02 [95%CI: -0.24, 0.19], I2: 
70.8%, p=0.826). 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 -1.35 0.36 0.000
Giacco 2013 -0.06 0.18 0.754
Giacco 2014 0.00 0.27 1.000
Harris Jackson 2014 1.95 0.34 0.000
Kikuchi 2018 -0.09 0.29 0.760
Kirwan 2016 0.03 0.25 0.888
Kondo 2017 -0.28 0.38 0.459
Kristensen 2012 -0.13 0.24 0.586
Kristensen 2017 0.00 0.15 1.000
Maki 2010 -0.20 0.17 0.242
Pins 2002 0.21 0.21 0.336
Roager 2019 -0.11 0.20 0.586
Schutte 2018 -0.25 0.28 0.375
Shimabukuro 2014 per1 -0.22 0.27 0.413
Shimabukuro 2014 per2 -0.07 0.27 0.811
Vitaglione 2015 0.17 0.24 0.494
Fixed -0.03 0.06 0.578
Random -0.02 0.11 0.826
-3.00 -1.50 0.00 1.50 3.00
Favours Intervention Favours Control
Weight
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Figure S19: Whole grains compared with refined grains had a significant effect on waist circumference (SMD: -0.09 [95%CI: -0.25, 0.05], I2: 
35.5%, p=0.117). 
 
Model Study name Statistics for each study Std diff in means and 95% CI
Std diff Standard 
in means error p-Value
Araki 2017 -1.19 0.36 0.001
Giacco 2013 -0.04 0.18 0.837
Giacco 2014 0.02 0.27 0.945
Harris Jackson 2014 0.46 0.29 0.111
Kikuchi 2018 -0.05 0.29 0.860
Kirwan 2016 0.06 0.25 0.809
Kristensen 2012 0.00 0.24 1.000
Kristensen 2017 0.03 0.15 0.863
Maki 2010 -0.41 0.17 0.015
Roager 2019 -0.16 0.20 0.434
Schutte 2018 -0.32 0.28 0.259
Shimabukuro 2014 per2 -0.26 0.27 0.350
Vitaglione 2015 -0.03 0.24 0.898
Zhang 2011 0.04 0.14 0.781
Fixed -0.09 0.06 0.115
Random -0.10 0.07 0.177
-2.00 -1.00 0.00 1.00 2.00
Favours Intervention Favours Control
Waist
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Figure S20: Funnel plot assessing publication bias of studies pooled to determine the effect of whole grains compared to refined grains on CRP/hs-CRP. 
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Figure S21: Funnel plot assessing publication bias of studies pooled to determine the effect of whole grains compared to refined grains on total cholesterol. 
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Figure S22: Funnel plot assessing publication bias of studies pooled to determine the effect of whole grains compared to refined grains on total body weight 
change. 

















Funnel Plot of Standard Error by Difference in means
Online Supplementary Material 1 
The effect of replacing refined grains with whole grains on cardiovascular risk factors:  A systematic review and meta-analysis of 
randomized controlled trials with GRADE clinical recommendation 
 
Figure S22: Funnel plot assessing publication bias of studies pooled to determine the effect of whole grains compared to refined grains on HbA1c%. 
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Figure 1: Flow diagram of identified records which were screened according to the search 
strategy. 
 
Records identified in databases  
(n = 10,706) 
PubMed (n = 2,437) 
CINAHL (n = 3,630) 
Cochrane Library (n = 146) 
Embase (n = 3,442) 































Additional records identified 
through other sources 
(n = 1) 
Records screened for 
title/abstract after duplicates 
removed 
(n = 8,095) 
Records excluded 
(n = 7,901) 
Full-text articles assessed for 
eligibility 
(n = 194) 
Full-text articles excluded, 
with reasons 
(n = 164) 
Wrong intervention (n = 98) 
Wrong comparator (n = 24) 
Conference abstract (n = 17) 
Wrong outcomes (n = 12) 
Wrong study design (n = 7) 
Duplicate (n = 4) 
Unable to be translated to 
English (n = 2) 
 
n = 30 publications included 
in qualitative synthesis 
from n=25 RCTs 
n= 22 publications included 
in quantitative synthesis 
(meta-analysis) from 




Table 1: Inclusion and exclusion criteria of a systematic review and meta-analysis of randomized controlled trials which compare whole grain or 
whole pseudo-grain interventions and placebo or refined grain controls in humans. 
 Inclusion criteria Exclusion criteria  
Participants  Humans 
 Healthy adults, adults with CVDa risk factors, CVD, metabolic 
syndrome, or T2DMb. 
 The sample population exclusively includes participants who are pregnant or 
have any other chronic diseases not directly associated with CVD-risk. 
Interventions  Whole grain or pseudo-grain met the HEALTHGRAINc EU 
Consortium definition and food products contained >50% whole 
grain. 
 The background diet between groups was standardized or 
controlled. 
 Other intervention factors could be included if they were 
implemented in both groups e.g. energy-restriction, voluntary 
fortification. 
 Intervention length ≥2 weeks for studies which reported 
inflammatory or oxidative stress markers as outcomes; or ≥8 
weeks for studies which reported all other eligible outcomes
b
. 
 Does not meet the HEALTHGRAIN EU criteria for whole grain. 
 Does not describe the whole grain intervention product in sufficient detail as to 
ascertain if it meets the HEALTHGRAIN EU criteria. 
 Whole grain product is fortified with additional nutrients or functional 
ingredients which are not subject to mandatory fortification. 
 The intervention was implemented by dietary recommendations where the 
whole grain product was not provided to participants. 
 The intervention co-administers other non-whole grain aspects not implemented 
in the control group e.g. other dietary products or lifestyle modifications. 
Comparators and 
outcomes 
 Control group receiving refined grain or placebo.  No outcomes of interest are included. 
a. CVD, cardiovascular disease;  
b. T2DM, type II diabetes mellitusc 
c.  “The intact grain or the dehulled, ground, milled, cracked or flaked grain where the constituents—endosperm, germ and bran—are present in such proportions that 
represent the typical ratio of those fractions occurring in the whole cereal, and includes wholemeal”4 
 
For studies with a duration between two and eight weeks which reported inflammatory and oxidative markers as well as other relevant outcomes, only inflammatory and 
oxidative stress outcomes were retrieved and considered in this review.   
Table 2: Search strategy implemented across five electronic databases and results of total records retrieved when searching for randomized 
controlled trials which compare whole grain or whole pseudo-grain interventions and placebo or refined grain controls in humans. 
Set Search Terms 
MEDLINE (via PubMed) - searched 8 March 2019 using keywords (title and abstract) and MeSH Terms. Result = 2,437 records 
1. (((clinical trial[MeSH Terms]) OR (("clinical trial"[Title/Abstract] OR "controlled trial"[Title/Abstract] OR "equivalence trial"[Title/Abstract] OR 
intervention[Title/Abstract] OR "cross-over"[Title/Abstract] OR randomized[Title/Abstract] OR randomized[Title/Abstract] OR "control trial"[Title/Abstract] 
OR placebo[Title/Abstract])))) AND (((("edible grain"[Title/Abstract] OR secale[Title/Abstract] OR triticale[Title/Abstract] OR triticum[Title/Abstract] OR 
avena[Title/Abstract] OR "setaria plant"[Title/Abstract] OR hordeum[Title/Abstract] OR oryza[Title/Abstract] OR "zea mays"[Title/Abstract] OR 
eragrostis[Title/Abstract] OR teff[Title/Abstract] OR sorghum[Title/Abstract] OR johnsongrass[Title/Abstract] OR "kaffir corn"[Title/Abstract] OR 
kafir[Title/Abstract] OR sudangrass[Title/Abstract] OR triticale[Title/Abstract] OR triticosecale[Title/Abstract] OR triticum[Title/Abstract] OR 
Fagopyrum[Title/Abstract] OR buckwheat[Title/Abstract] OR celosia[Title/Abstract] OR durum[Title/Abstract] OR rye[Title/Abstract] OR barley[Title/Abstract] 
OR maize[Title/Abstract] OR teosinte[Title/Abstract] OR zea[Title/Abstract] OR cereal*[Title/Abstract] OR grain*[Title/Abstract] OR *grain[Title/Abstract] OR 
*germ[Title/Abstract] OR *bran[Title/Abstract] OR endosperm[Title/Abstract] OR wholegrain*[Title/Abstract] OR wholemeal[Title/Abstract] OR 
wheat[Title/Abstract] OR oat[Title/Abstract] OR oats[Title/Abstract] OR millet[Title/Abstract] OR setaria[Title/Abstract] OR panicum[Title/Abstract] OR 
rice[Title/Abstract] OR corn[Title/Abstract] OR flour[Title/Abstract] OR semolina[Title/Abstract] OR bulgar[Title/Abstract] OR groats[Title/Abstract] OR 
bread[Title/Abstract] OR porridge[Title/Abstract] OR cracker[Title/Abstract] OR biscuit[Title/Abstract] OR muesli[Title/Abstract] OR pancake*[Title/Abstract] 
OR pasta[Title/Abstract] OR noodle*[Title/Abstract] OR polenta[Title/Abstract] OR muffin*[Title/Abstract] OR roll[Title/Abstract] OR dough[Title/Abstract] 
OR durum[Title/Abstract] OR spelt[Title/Abstract] OR spelta[Title/Abstract] OR emmer[Title/Abstract] OR dicoccon[Title/Abstract] OR 
khorasan[Title/Abstract] OR turanicum[Title/Abstract] OR einkorn[Title/Abstract] OR monococcum[Title/Abstract] OR "hard red spring"[Title/Abstract] OR 
"hard red winter"[Title/Abstract] OR "soft red winter"[Title/Abstract] OR "hard white"[Title/Abstract] OR "soft white"[Title/Abstract] OR teff[Title/Abstract] 
OR eragrostis[Title/Abstract] OR "Williams lovegrass"[Title/Abstract] OR "annual bunch grass"[Title/Abstract] OR pumpernickel[Title/Abstract] OR 
Fagopyrum[Title/Abstract] OR quinoa[Title/Abstract] OR amaranth*[Title/Abstract] OR chia[Title/Abstract] OR chiaseed[Title/Abstract] OR 
granola[Title/Abstract] OR tortilla*[Title/Abstract] OR "maya nut"[Title/Abstract] OR *bread[Title/Abstract] OR colosia[Title/Abstract] OR 
cockscomb[Title/Abstract] OR "quail grass"[Title/Abstract] OR soko[Title/Abstract] OR "pitseed goosefoot"[Title/Abstract] OR berlandieri[Title/Abstract] OR 
kaniwa[Title/Abstract] OR "Chenopodium pallidicaule"[Title/Abstract] OR canihua[Title/Abstract] OR qaniwa[Title/Abstract] OR wattleseed[Title/Abstract] OR 
"acacia seed"[Title/Abstract] OR "wattle seed"[Title/Abstract] OR kamut[Title/Abstract] OR Fagopyrum[Title/Abstract]))) AND (((((((edible grain[MeSH 
Terms]) OR secale[MeSH Terms]) OR ((((((((((triticale[MeSH Terms]) OR triticum[MeSH Terms]) OR flour[MeSH Terms]) OR bread[MeSH Terms]) OR 
avena[MeSH Terms]) OR setaria plant[MeSH Terms]) OR hordeum[MeSH Terms]) OR oryza[MeSH Terms]) OR zea mays[MeSH Terms]) OR eragrostis[MeSH 
Terms])) OR ((((((((((teff[MeSH Terms]) OR sorghum[MeSH Terms]) OR johnsongrass[MeSH Terms]) OR kaffir corn[MeSH Terms]) OR kafir[MeSH Terms]) 
OR sorghum bicolor[MeSH Terms]) OR sorghum halepense[MeSH Terms]) OR sudangrass[MeSH Terms]) OR triticale[MeSH Terms]) OR triticosecale[MeSH 
Terms])) OR (((((((triticum x secale[MeSH Terms]) OR Fagopyrum[MeSH Terms]) OR Fagopyrum esculentum[MeSH Terms]) OR Fagopyrum sagittatum[MeSH 
Terms]) OR Fagopyrum tataricum[MeSH Terms]) OR buckwheat[MeSH Terms]) OR Chenopodium quinoa[MeSH Terms])) OR ((((((((quinoa[MeSH Terms]) 
OR amaranthus[MeSH Terms]) OR celosia[MeSH Terms]) OR durum wheat[MeSH Terms]) OR triticum aestivum[MeSH Terms]) OR triticum durum[MeSH 
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Terms]) OR triticum spelta[MeSH Terms]) OR triticum turgidum[MeSH Terms])) OR ((((((((((((((((triticum turgidum subsp. Durum[MeSH Terms]) OR triticum 
vulgare[MeSH Terms]) OR wheat[MeSH Terms]) OR rye[MeSH Terms]) OR secale cereale[MeSH Terms]) OR barley[MeSH Terms]) OR hordeum 
vulgare[MeSH Terms]) OR oats[MeSH Terms]) OR cultivated oat[MeSH Terms]) OR avena sativa[MeSH Terms]) OR rice[MeSH Terms]) OR oryza 
sativa[MeSH Terms]) OR corn[MeSH Terms]) OR Indian corn[MeSH Terms]) OR maize[MeSH Terms]) OR teosinte[MeSH Terms]))) 
CINAHL (via Ebscohost) was searched on 8 March 2019 using keywords (title and abstract) and CINAHL Subject Headings. Result = 3,630 records 
1. (MH “clinical trials+”) OR ( TI “clinical trial” or “controlled trial” or “equivalence trial” or intervention or “cross-over” or randomized or randomized or “control 
trial” or placebo ) OR ( AB “clinical trial” or “controlled trial” or “equivalence trial” or intervention or “cross-over” or randomized or randomized or “control 
trial” or placebo ) AND ( (MH “Cereals+”) or (MH “barley”) or (MH “corn”) or (MH “oats”) or (MH “rice”) or (MH “wheat”) or (MH “bread”) ) OR ( TI “edible 
grain” or secale or triticale or triticum or avena or “setaria plant” or hordeum or oryza or “zea mays” or eragrostis or teff or sorghum or johnsongrass or “kaffir 
corn” or kafir or sudangrass or triticale or triticosecale or triticum or Fagopyrum or buckwheat or celosia or durum or rye or barley or maize or teosinte or zea or 
cereal* or grain* or *grain or *germ or *bran or endosperm or wholegrain* or wholemeal or wheat or oat or oats or millet or setaria or panicum or rice or corn or 
flour or semolina or bulgar or groats or bread or porridge or cracker or biscuit or muesli or pancake* or pasta or noodle* or polenta or muffin* or roll or dough or 
durum or spelt or spelta or emmer or dicoccon or khorasan or turanicum or einkorn or monococcum or “hard red spring” or “hard red winter” or “soft red winter” 
or “hard white” or “soft white” or teff or eragrostis or “Williams lovegrass” or “annual bunch grass” or pumpernickel or Fagopyrum or quinoa or amaranth* or 
chia or chiaseed or granola or tortilla* or “maya nut” or *bread or colosia or cockscomb or “quail grass” or soko or “pitseed goosefoot” or berlandieri or kaniwa 
or “Chenopodium pallidicaule” or canihua or qaniwa or wattleseed or “acacia seed” or “wattle seed” or kamut or Fagopyrum ) OR ( AB “edible grain” or secale 
or triticale or triticum or avena or “setaria plant” or hordeum or oryza or “zea mays” or eragrostis or teff or sorghum or johnsongrass or “kaffir corn” or kafir or 
sudangrass or triticale or triticosecale or triticum or Fagopyrum or buckwheat or celosia or durum or rye or barley or maize or teosinte or zea or cereal* or grain* 
or *grain or *germ or *bran or endosperm or wholegrain* or wholemeal or wheat or oat or oats or millet or setaria or panicum or rice or corn or flour or semolina 
or bulgar or groats or bread or porridge or cracker or biscuit or muesli or pancake* or pasta or noodle* or polenta or muffin* or roll or dough or durum or spelt or 
spelta or emmer or dicoccon or khorasan or turanicum or einkorn or monococcum or “hard red spring” or “hard red winter” or “soft red winter” or “hard white” 
or “soft white” or teff or eragrostis or “Williams lovegrass” or “annual bunch grass” or pumpernickel or Fagopyrum or quinoa or amaranth* or chia or chiaseed 
or granola or tortilla* or “maya nut” or *bread or colosia or cockscomb or “quail grass” or soko or “pitseed goosefoot” or berlandieri or kaniwa or “Chenopodium 
pallidicaule” or canihua or qaniwa or wattleseed or “acacia seed” or “wattle seed” or kamut or Fagopyrum ) 
The Cochrane Library was searched on 8 March 2019 using keywords and MeSH Headings. Result = 146 “Trials” records 
1. ‘MeSH descriptor: [Clinical Trials as Topic] explode all trees’  
2. (“edible grain” or secale or triticale or triticum or avena or “setaria plant” or hordeum or oryza or “zea mays” or eragrostis or teff or sorghum or johnsongrass or 
“kaffir corn” or kafir or sudangrass or triticale or triticosecale or triticum or Fagopyrum or buckwheat or celosia or durum or rye or barley or maize or teosinte 
or zea or cereal* or grain* or *grain or *germ or *bran or endosperm or wholegrain* or wholemeal or wheat or oat or oats or millet or setaria or panicum or rice 
or corn or flour or semolina or bulgar or groats or bread or porridge or cracker or biscuit or muesli or pancake* or pasta or noodle* or polenta or muffin* or roll 
or dough or durum or spelt or spelta or emmer or dicoccon or khorasan or turanicum or einkorn or monococcum or “hard red spring” or “hard red winter” or 
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“soft red winter” or “hard white” or “soft white” or teff or eragrostis or “Williams lovegrass” or “annual bunch grass” or pumpernickel or Fagopyrum or quinoa 
or amaranth* or chia or chiaseed or granola or tortilla* or “maya nut” or *bread or colosia or cockscomb or “quail grass” or soko or “pitseed goosefoot” or 
berlandieri or kaniwa or “Chenopodium pallidicaule” or canihua or qaniwa or wattleseed or “acacia seed” or “wattle seed” or kamut or Fagopyrum):ti 
3. (“edible grain” or secale or triticale or triticum or avena or “setaria plant” or hordeum or oryza or “zea mays” or eragrostis or teff or sorghum or johnsongrass or 
“kaffir corn” or kafir or sudangrass or triticale or triticosecale or triticum or Fagopyrum or buckwheat or celosia or durum or rye or barley or maize or teosinte 
or zea or cereal* or grain* or *grain or *germ or *bran or endosperm or wholegrain* or wholemeal or wheat or oat or oats or millet or setaria or panicum or rice 
or corn or flour or semolina or bulgar or groats or bread or porridge or cracker or biscuit or muesli or pancake* or pasta or noodle* or polenta or muffin* or roll 
or dough or durum or spelt or spelta or emmer or dicoccon or khorasan or turanicum or einkorn or monococcum or “hard red spring” or  “hard red winter” or 
“soft red winter” or “hard white” or “soft white” or teff or eragrostis or “Williams lovegrass” or “annual bunch grass” or pumpernickel or Fagopyrum or quinoa 
or amaranth* or chia or chiaseed or granola or tortilla* or “maya nut” or *bread or colosia or cockscomb or “quail grass” or soko or “pitseed goosefoot” or 
berlandieri or kaniwa or “Chenopodium pallidicaule” or canihua or qaniwa or wattleseed or “acacia seed” or “wattle seed” or kamut or Fagopyrum):ab 
4. 2 or 3 
5. 1 and 4 
EMBASE was searched 8 March 2019 for citations from both Embase and MEDLINE using keywords (abstract and title) and Emtree terms. Result = 3,442 records 
1. [Emtree] ‘clinical trial’/exp 
2. [Emtree] 'food grain'/exp OR 'cereal'/exp OR 'barley'/exp OR 'bread'/exp OR 'breakfast cereal'/exp OR 'finger millet'/exp OR 'foxtail millet'/exp OR 'maize'/exp 
OR 'field corn'/exp OR 'sweet corn'/exp OR 'malt'/exp OR 'millet'/exp OR 'oat'/exp OR 'pearl millet'/exp OR 'rice'/exp OR 'Indian rice'/exp OR 'Japonica 
rice'/exp OR 'rye'/exp OR 'sorghum'/exp OR 'sudangrass'/exp OR 'wheat'/exp OR 'emmer'/exp OR 'spelt'/exp OR 'spring wheat'/exp OR 'triticale'/exp OR 
'Triticum aestivum'/exp OR 'Triticum durum'/exp OR 'Triticum monococcum'/exp OR 'Triticum turgidum'/exp OR 'wheat germ'/exp OR 'winter wheat'/exp OR 
'grain flour'/exp OR 'barley flour'/exp OR 'corn flour'/exp  OR 'oatmeal'/exp OR 'rice flour'/exp OR 'rye flour'/exp OR 'semolina'/exp OR 'sorghum flour'/exp OR 
'wheat flour'/exp OR 'pseudocereal'/exp OR 'buckwheat'/exp OR 'Chenopodium quinoa'/exp OR 'chia'/exp OR 'refined grain'/exp OR 'whole grain'/exp OR 
'dough'/exp OR 'bakery product'/exp OR 'biscuit'/exp OR 'cookie'/exp OR 'dough'/exp 
3. “edible grain”:ab,ti or secale:ab,ti or triticale:ab,ti or triticum:ab,ti or avena:ab,ti or “setaria plant”:ab,ti or hordeum:ab,ti or oryza:ab,ti or “zea mays”:ab,ti or 
eragrostis:ab,ti or teff:ab,ti or sorghum:ab,ti or johnsongrass:ab,ti or “kaffir corn”:ab,ti or kafir:ab,ti or sudangrass:ab,ti or triticale:ab,ti or triticosecale:ab,ti or 
triticum:ab,ti or Fagopyrum:ab,ti or buckwheat:ab,ti or celosia:ab,ti or durum:ab,ti or rye:ab,ti or barley:ab,ti or maize:ab,ti or teosinte:ab,ti or zea:ab,ti or 
cereal*:ab,ti or grain*:ab,ti or grain:ab,ti or germ:ab,ti or bran:ab,ti or endosperm:ab,ti or wholegrain*:ab,ti or wholemeal:ab,ti or wheat:ab,ti or oat:ab,ti or 
oats:ab,ti or millet:ab,ti or setaria:ab,ti or panicum:ab,ti or rice:ab,ti or corn:ab,ti or flour:ab,ti or semolina:ab,ti or bulgar:ab,ti or groats:ab,ti or bread:ab,ti or 
porridge:ab,ti or cracker:ab,ti or biscuit:ab,ti or muesli:ab,ti or pancake*:ab,ti or pasta:ab,ti or noodle*:ab,ti or polenta:ab,ti or muffin*:ab,ti or roll:ab,ti or 
dough:ab,ti or durum:ab,ti or spelt:ab,ti or spelta:ab,ti or emmer:ab,ti or dicoccon:ab,ti or khorasan:ab,ti or turanicum:ab,ti or einkorn:ab,ti or monococcum:ab,ti 
or “hard red spring”:ab,ti or “hard red winter”:ab,ti or “soft red winter”:ab,ti or “hard white”:ab,ti or “soft white”:ab,ti or teff:ab,ti or eragrostis:ab,ti or “Williams 
lovegrass”:ab,ti or “annual bunch grass”:ab,ti or pumpernickel:ab,ti or quinoa:ab,ti or amaranth*:ab,ti or chia:ab,ti or granola:ab,ti or tortilla*:ab,ti or “maya 
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nut”:ab,ti or bread:ab,ti or colosia:ab,ti or cockscomb:ab,ti or “quail grass”:ab,ti or soko:ab,ti or “pitseed goosefoot”:ab,ti or berlandieri:ab,ti or kaniwa:ab,ti or 
“Chenopodium pallidicaule”:ab,ti or canihua:ab,ti or qaniwa:ab,ti or wattleseed:ab,ti or “acacia seed”:ab,ti or “wattle seed”:ab,ti or kamut:ab,ti  
4. 2 or 3 
5. 1 and 4 
6. 5 and ([adult]/lim OR [aged]/lim OR [middle aged]/lim OR [very elderly]/lim) AND ( 'clinical article'/de OR 'clinical trial'/de OR 'controlled clinical trial'/de 
OR 'controlled study'/de OR 'crossover procedure'/de OR 'double blind procedure'/de OR 'human'/de OR 'major clinical study'/de OR 'multicenter study'/de 
OR 'normal human'/de OR 'phase 1 clinical trial'/de OR 'phase 2 clinical trial'/de OR 'pilot study'/de OR 'randomized controlled trial'/de OR 'single blind 
procedure'/de) AND ('article'/it OR 'article in press'/it) 
Web of Science was searched 8 March 2019 for the following keywords in title. Results = 968 records 
1. TITLE: “edible grain” or secale or triticale or triticum or avena or “setaria plant” or hordeum or oryza or “zea mays” or eragrostis or teff or sorghum or 
johnsongrass or “kaffir corn” or kafir or sudangrass or triticale or triticosecale or triticum or Fagopyrum or buckwheat or celosia or durum or rye or barley or 
maize or teosinte or zea or cereal* or grain* or *grain or *germ or *bran or endosperm or wholegrain* or wholemeal or wheat or oat or oats or millet or setaria 
or panicum or rice or corn or flour or semolina or bulgar or groats or bread or porridge or cracker or biscuit or muesli or pancake* or pasta or noodle* or polenta 
or muffin* or roll or dough or durum or spelt or spelta or emmer or dicoccon or khorasan or turanicum or einkorn or monococcum or “hard red spring” or “hard 
red winter” or “soft red winter” or “hard white” or “soft white” or teff or eragrostis or “Williams lovegrass” or “annual bunch grass” or pumpernickel or 
Fagopyrum or quinoa or amaranth* or chia or chiaseed or granola or tortilla* or “maya nut” or *bread or colosia or cockscomb or “quail grass” or soko or 
“pitseed goosefoot” or berlandieri or kaniwa or “Chenopodium pallidicaule” or canihua or qaniwa or wattleseed or “acacia seed” or “wattle seed” or kamut or 
Fagopyrum 
2. TITLE: “clinical trial” or “controlled trial” or “equivalence trial” or intervention or “cross-over” or randomized or randomized or “control trial” or placebo 
3. 1 and 2 




Table 3: Sample and study design characteristics of the 25 included randomized controlled trials (reported across 30 publications) which 






Sample  Duration 
 


















CG=12). Attrition: IG 
8%, CG 8%. 
µ51 ± 7yd; 0% Fe. 








Food source: Barley 
bread, buns, 
muffins, cookies, 
pasta, cereal. Made 
























IG, 1 CG). 
N=33 (IG=33; 
CG=33). Attrition: IG 
0%, CG 0%. µ49 ±1 







Grain: Mixed (59% 
wheat, 40% oats, 1% 
corn and rice). 
Food source: 
Commercially 









available pasta, rice, 
snacks, and breakfast 
cereals. 
Dose: Unspecified; 
consumed RGm; mean 



























IG, 1 CG). 
N=34 (IG=34; 
CG=34). Attrition: IG 
12%, CG 12%. µ59 ± 















pasta, rice, flour. 
Dose: µ112g/d. 
Grain: Mixed (wheat, 

















Enright et al 






IG, 1 CG). 
N=20 (IG=20; 
CG=20). Attrition: IG 
0%, CG 0%. µ27 ± 














Dose: M: 8 
servings/d, F:6 
servings/d. Standard 
serving: 1 slice of 
bread, 1/2Cq cereal, 
others not specified. 






crackers, buns, bagels. 
Wheat and rice mostly 
puffed. 
Dose: Mp: 8 
servings/d, F:6 
servings/d. Standard 
serving: 1 slice of 
bread, 1/2C cereal, 








NM. Oxidative stress 
markers. 
 
Giacco et al 







IG, 1 CG). 
N=146 (IG=75; 
CG=71). Attrition: IG 
19%, CG 13%. Age 







(wheat, barley, oat, 
rye). 
Food source: Bread, 




Dose: µ136 ±18g/d. 




available bread, rice, 
pizza, porridge, 
breakfast cereal.  
Dose: 60-80% of 
carbohydrate intake; 
0g WG intake. 
Isocaloric. 
Controlled via 
4-week run in 
period; in which 


















Giacco et al 
2014 31.  
Italy. 
N=61 (IG=30; 
CG=31). Attrition: IG 
7%, CG 16%. µ57 ± 











blood lipids, body 
composition. 





CG=19). Attrition: IG 
0%, CG 0%. µ58 ± 








Jackson et al 






CG=32). Attrition: IG 





(wheat, rice, oat). 
Food source: 
Pancakes, bread roll, 
Grain: Mixed (wheat, 
rice, corn). 
Food source: 














IG, 1 CG). 





pasta, cookies; others 
ND.  






Kirwan et al 








CG=40). Attrition: IG 
18%, CG 18%. µ39 ± 
















































Malin et al 
2019 37.  
USA. 
N=14 (IG=14; 
CG=14). Attrition: IG 
0%, CG 0%. µ38 ± 




Malin et al 
2019 35. 
USA 
N13 (IG=13; CG=13). 
Attrition: IG 0%, CG 




Kondo et al 






IG, 1 CG). 
N=29 (IG=14; 
CG=15). Attrition: IG 
0%, CG 7%. µ67 ± 









Food source: Packet 
of mixed grain to 
cook as per 
preference. 
Dose: Staple food 
for 10/21 meals/wk. 
Grain: White rice. 
Food source: ND. 






















CG=89). Attrition: IG 
9%, CG 1%. µ36 ± 











rice, pasta, rusks, 
crispbread, breakfast 
cereal, cereal bar. 





couscous, rice, pasta, 
rusks, breakfast cereal. 
Dose: ND, Mean 
0.5g/d of WG. 
Hypocaloric, 
controlled with 





















Dose: µ124 ±1.7g/d. 
Roager et al 






IG, 1 CG). 
N=60 (IG=60; 
CG=60). Attrition: IG 
17%, CG 17%. µ49 ± 







Grain: Mixed (oat, 
rye, wheat, bulgur) 
Food source: 
Breakfast cereal, 
bread, buns, pasta, 
crisps  
Dose: >122g/d.  
Grain: Mixed (wheat, 






























Attrition: IG 5%, IG 
4%, CG 17%. µ52 ± 




IG 1. Grain: Mixed 
(wheat, oat) 
Food source: Bread, 
cereal, rolled oats. 
Dose: >60g/d  
IG 1 reported below. 
Grain: Refined wheat. 


















Vanegas et al 






IG, 1 CG). 
N=90 (IG=45; 
CG=45). Attrition: IG 
9%, CG 11%. µ55 ± 







Food source: Bread. 
Dose: 16g/1000kcal.  
Grain: Mixed (mostly 
wheat). 





run-in phase and 























IG, 1 CG). 
N=204 (IG=101; 
CG=103). Attrition: 
IG 24%, CG 35%. 









available oat cereal 
(Cheerios). 
Dose: 3C/d.  





cereal, bread, bagel, 
muffin, chips, 
crackers, or rice cakes. 
Dose: ND; kJ 
consumption of RG 
Hypocaloric; 
diet prescribed 







matched that provided 
by the WG. 
Pins et al 






IG, 1 CG). 
N=88 (IG=45; 
CG=43). Attrition: IG 
0%, CG 0%. µ48y 
(range: 33-67y). 







oatmeal and oat 
squares. 
Dose: 137g/d. 






























IG, 1 CG) 
N=41 (IG=20; 
CG=21). Attrition: IG: 
5%, CG 14%. µ54 ± 









Grain: White rice. 
Food source: ND. 
Dose: 400g/d. 
Study provided 
2 main meals; 
participants able 
to eat staple 
foods for 3rd 
meal. 




body composition.  
Kazemzadeh 






IG, 1 CG) 
N=38 (IG=38; 
CG=38). Attrition: IG 
8%, CG 8%. µ33 ± 






Grain: Brown rice 
Food source: Iranian 
rice variety (Tarom) 
Dose: 150g/d.  
Grain: White rice 
Food source: Iranian 













Kim et al 






IG, 1 CG). 
47 (IG=23; CG=24) 
Attrition: IG 13%, CG 





Grain: Brown and 
black rice. 
Food source: served 
within a meal 
substitute. 
Dose: 3 servings/d; 
ND further. 
Grain: White rice. 
Food source: served 
within a meal 
substitute. 





N/A. Oxidative stress 
markers. 
Nakayama et 






IG, 1 CG). 
N=18 (IG=18; 
CG=18). Attrition: IG 
11%, CG 11%. µ64 ± 











Dose: 2 servings/d; 
serving size ND. 
Grain: White rice. 
Food source: ND. 
Dose:  2 servings/d; 
















IG, 1 CG). 
N=28 (IG=28; 
CG=28). Attrition: IG 
4%, CG 4%. µ46 ± 







Grain: Brown rice. 
Food source: ND.  
Dose: consumed 
daily; ND further.  
Grain: white rice. 
Food source: ND. 















Zhang et al 






IG, 1 CG). 
N=202 (IG=101; 
CG=101). Attrition: 
IG 3%, CG 6%. µ50 ± 






Grain: Brown rice 
Food source: soaked 
in water for 1hr 
before cooking. 
Dose: 225g/d.  
Grain: White rice 
Food source: ND  













Giacco et al 






IG, 1 CG). 
N=15 (IG=15; 
CG=15). Attrition: 
IG: 0%, CG 0%. µ55 













Dose: ND; included 
WG at every meal. 
Grain: Refined wheat. 
Food source: 
Commercially 
available pasta, bread, 
rusks, crackers. 
Dose: Not specified; 













Kikuchi et al 






IG, 1 CG). 
N=50 (IG=25; 
CG=25). Attrition: IG 
4%, CG 0%. µ48 ± 




Grain: WG wheat. 
Food source: Bread 
prepared for the 
study. 
Dose: µg/day (range 
-g/d). 
Grain: Refined wheat. 
Food source: Refined 
bread dyed brown, 
prepared for the study. 
Dose: ND; assumed 




















IG, 1 CG). 
N=79 (IG=42; 
CG=37). Attrition: IG 
10%, CG 8%. µ60 ± 












Grain: Refined wheat. 
Food source: 
Commercially 























Dose: Grain foods 
were the same portion 
sizes as WG. 
Schutte et al 






IG, 1 CG). 
N=50 (IG=25; 
CG=25). Attrition: IG 
0%, CG 0%. µ61y 
(range: 51-69y). 48% 





Grain: WG wheat 
Food source: Bread, 
cereal, buns 
Dose: 98g/d. 
Grain: Refined wheat 
Food source: White 
bread, buns, cereal 
Dose: 98g/d. 
Unchanged from 
usual diet, asked 
to maintain not 



























Attrition: IG 5%, IG 
4%, CG 17%. µ52 ± 






IG 2. Grain: WG 
wheat 
Food source: Bread, 
cereal 
Dose: >60g/d  
IG 2 reported above 
Grain: Refined wheat. 



























CG=40). Attrition: IG 
10%, CG 20%. µ39 ± 









Grain: Refined wheat. 














a. RCT, randomized controlled trial 
b. IG, intervention group 
c. CG, comparator group 
d. y, year. 
e. F, females 
f. CVD, cardiovascular disease 
g. wks, weeks 
h. g, grams 
i. d, day 
j. ND, not described 
k. NM, not measured 
l. UK, United Kingdom 
m. RG, refined grain 
n. WG, whole grain 
o. USA, United States of America 
p. M, males 
q. C, cup 
r. Corn was not considered as a grain by the study investigators, and was therefore provided as part of the background diet to both groups. 
s. 62% of participants had insufficient alkyresorcinol levels indicating non-adherence. 







Table 4: Justification for the risk of bias assessment according to the Cochrane Risk of Bias tool 20 of randomized controlled trials which 
compare whole grain or whole pseudo-grain interventions and placebo or refined grain controls in humans. 























Low risk of bias Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 
Evidence "Subjects were 
randomized based 
on age, gender 
and BMI 
by a research 
assistant, who was 
not involved in 




No description of 
allocation 
concealment 
No parties were blinded. 
There were no measures 
taken to minimize risk of 
bias in regards to 
blinding. 






0% attrition for 
both groups 
None detected. None detected. 
Rating Andersso
n 2007 57 
Unclear Unclear High risk of bias Low risk of bias Low risk of bias Unclear Low risk of bias 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 
No parties were blinded. 
There were no measures 
taken to minimize risk of 
bias in regards to 
blinding. 









was not related to 
study  
4 participants 
dropped out; but 
there are an 
additional 2 for 
whom data is not 


































Rating  Araki 
2017 52 
Unclear Unclear High risk of bias Low risk of bias Low risk of bias High risk of bias Unclear 








PABR or WR 
with an allocation 
table prepared by 
a data coordinator 








C) levels (>140 
mg/dL or not)." 








PABR or WR 
with an allocation 
table prepared by 
a data coordinator 








C) levels (>140 
mg/dL or not)." 
No parties were blinded. 
There were no measures 
taken to minimize risk of 
bias in regards to 
blinding. 







was higher in IG 
(14%) compared 
to CG (5%), 
attrition was not 





pressure and BMI 






the CG, did not 
report final values 
but only change 
values. Many of 
the statistically 
significant results 
were presented in 
figures only with 
no report of actual 
data. 
Analysis of 
findings found no 
statistically 
significant results; 
however, there is 






excluded due to 
an error in the 
study product at 
the 
commencement of 
the study) which 
suggests analysts 
were mining for 
results. 
Background diet 
was not well 
controlled beyond 
basic advise, and 





Unclear Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 
No parties were blinded. 
There were no measures 
taken to minimize risk of 
bias in regards to 
blinding. 




No attrition for 
either group. 
None detected. None detected. 
























Unclear Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 
Evidence  No description of 
randomization 
technique 
No description of 
allocation 
concealment 
No parties were blinded. 
There were no measures 
taken to minimize risk of 
bias in regards to 
blinding. 






No attrition for 
either group. 
None detected. None detected. 
Rating Giacco 
2013 40 
Low risk of bias Low risk of bias High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 
Evidence "Randomization 
was carried out 
with stratification 
for sex, age,  
and body mass 
index (BMI) by 





carried out by 
personnel not 












dieticians were aware of 
the participants’ group 
allocation" ; no 




aware of the 
participants’ 
group allocation"  
however, the 
outcome of 




lowest in the IG 
group; none 
related to study 
procedures. 
None detected. None detected. 
Rating Giacco 
2014 31 
Low risk of bias Low risk of bias High risk of bias Low risk of bias Low risk of bias Low risk of bias Unclear 
Evidence As per Giacco 
2013 
As per Giacco 
2013 
As per Giacco 2013. 
Laboratory analyses 
were performed blind in 





aware of the 
participants’ 
group allocation" 
;  however, the 
outcome of 
interest is an 
Attrition <20%; 
lowest in the IG 
group; none 
related to study 
procedures. 
Blood pressure 
was reported as 
measured in the 




were pooled with 
the Finland 
This study reports 
outcomes not of 
interest to this 
































for the whole 
cohort. This may 
lead to results 




Low risk of bias Low risk of bias High risk of bias Low risk of bias Low risk of bias Low risk of bias Unclear 
Evidence As per Giacco 
2013 
As per Giacco 
2013 
"investigators and 
dieticians were aware of 
the participants’ group 
allocation" ; no 




aware of the 
participants’ 
group allocation" 
;  however, the 
outcome of 
interest is an 
objective 
biomarker 
No attrition for 
either group; as 
only completers 
were selected for 
the sub analysis 
None detected. This study reports 
outcomes not of 
interest to this 







for the whole 
cohort. This may 
lead to results 










Rating Low risk of bias High risk of bias High risk of bias Low risk of bias Unclear Low risk of bias Low risk of bias 






























to either the WG 
or RG diet group 
for the entire 12 











age, sex, and BMI 
 
and conducted all 
data analyses" 
"Participants could not 









lowest in the IG 
group; 2 
participants in IG 
withdrew for 
reason related to 
diet - 1 caused 
minor adverse 
event, 1 could not 
comply. There 
may be some bias 
in the results, but 
numbers are very 
low so unlikely to 
substantially 
affect outcomes. 




Unclear Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 
"In the present work 
participant were not 
blinded" 
No description of 
blinding the 
personnel/researc
hers; however, the 
outcome of 









however, this rate 
is very low and 





None detected. None detected. 
Rating Unclear Unclear Low risk of bias Low risk of bias Low risk of bias Low risk of bias Unclear 























No description of 
randomization 
technique 
No description of 
allocation 
concealment 
"We added malt extract 
to refined wheat bread 
(RW diets) and colored it 
brown. RW diets and 
WW diets had almost 
same appearance. 
 And we decided 
formulation of tasteful 
bread (oil-rich and sugar-
rich), it was hard to feel 
difference in taste. As a 






intervention study was 
conducted" 
"We added malt 
extract to refined 
wheat bread (RW 
diets) and colored 
it brown. RW 
diets and WW 
diets had almost 
same appearance. 




rich), it was hard 
to feel difference 
in taste. As a 
















4% attrition in IG, 
0% in CG; very 
low attrition and 
none related to 
study. 





Rating Unclear Unclear Unclear Low risk of bias Low risk of bias Low risk of bias Unclear 























No description of 
randomization 
technique 
No description of 
allocation 
concealment 
The test products were 
contained within a meal 
replacement, and it 
shouldn't have been able 
to detect if they had RG 
or WG. But there is no 
description of 
concealment or blinding, 










because of a 
"dislike" of the 
diet, but exact 
numbers for 
withdrawal 
related to study 
procedures is not 
reported; 
regardless, it was 
equal across 
groups and was a 
low rate. 
None detected. The test products 
were poorly 
described and 
contained within a 
meal replacement, 
therefore not 
indicative of WG 
intake or 
consumed in a 
way that would be 
recommended. 




Unclear Unclear Low risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 




study" and " Blinding 
was achieved by 
covering whole-grain 
foods with sauce and by 
packaging meals into 
identical containers so 
that entrees appeared 
similar for both diets. 
Entrees were assembled 
at the Nestle Product 
Technology Center in 
Solon, Ohio." 





plus use of 
objective markers 
Overall attrition 
was 18%, reasons 
stated show that 
were unrelated to 
study. 
None detected. None detected. 
Rating Unclear Unclear Low risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 
























As per Kirwan 
2016 
As per Kirwan 
2016 
As per Kirwan 2016 As per Kirwan 
2016 
No attrition was 
reported for this 
sub-sample of 
Kirwan 2016 
None detected. None detected. 
Rating Kondo 
2017 45 
Low risk of bias Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 





provided with a 
random allocation 
sequence made by 
a research 








No description of 
allocation 
concealment 









Attrition was 7% 
in the CG, none in 
the IG. No 
attrition related to 
study processes. 
No systematic 
reporting bias was 
detected although 
an error was 





n 2012 58 
Unclear Unclear High risk of bias Unclear Low risk of bias Low risk of bias Low risk of bias 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 
"We used an open-
labeled design" 







and may have 
been influenced. 
Both groups had 
n=1 participant 
withdraw for 
reasons related to 
the test products. 
Overall attrition 
was low (<10%) 
and equal 
between groups. 
None detected. None detected. 
Rating Unclear Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias High risk of bias 






















n 2017 53 
No description of 
randomization 
technique 













related to study; 6 
unexplained. ITT 
analysis used. 
Low attrition in 
both groups. 






this was found to 
have a significant 




Unclear Unclear High risk of bias Unclear High risk of bias High risk of bias Low risk of bias 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 







and may have 
been influenced. 
Both groups had 
>20% attrition 





related to the 
study, but it 
appears several 
were related to the 
study. An ITT 
was attempted but 
the ITT results 
were reported 
inadequately to 
allow for any true 
review of the 
results. Attrition 
was high in the 
control group. 







not reported.  
None detected. 
Rating Unclear Unclear High risk of bias Unclear Low risk of bias Unclear Unclear 






















a 2017 55 
No description of 
randomization 
technique 
No description of 
allocation 
concealment 












due to study 
factors. 






tended to be 
reported, but as 
data is not 
presented as 
numerals it is had 










Unclear Unclear High risk of bias Low risk of bias Low risk of bias Unclear Low risk of bias 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 
No attempt at blinding Not blinded, but 
most outcomes 
were objective.  




Data was reported 
poorly and 
insufficiently, but 






Unclear Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Unclear 
Evidence No description of 
randomization 
technique 
No description of 
allocation 
concealment 












Rating Low risk of bias Low risk of bias High risk of bias Unclear Low risk of bias Low risk of bias Low risk of bias 























"Using a variable 
block size, the 
randomization list 
was generated by 
an investigator 
without contact to 
the participants,  











"Using a variable 
block size, the 
randomization list 
was 
generated by an 
investigator 
without contact to 
the participants, 











" It was not feasible to 
blind during the 
intervention, but 
participants and 
investigators involved in 
outcome assessment 
were blinded until the 
first examination day and 
during sample analysis 
and the initial data 
analysis. " 







and may have 
been influenced. 
2 withdrawals 
related to the 
study product (not 
clear if IG or 
CG); but overall 
attrition was low 
and compliance 
with products was 
good. 
None detected. None detected. 
Rating Schutte 
2018 48 
Low risk of bias Unclear Low risk of bias Low risk of bias Low risk of bias Low risk of bias Unclear 
Evidence "Randomization 







with the use of 
Microsoft Excel 
by a researcher 
who was not 
involved in the 
study" 
No description of 
allocation 
concealment 
"Both researchers and 
participants 
 
were blinded with regard 





were blinded with 
regard to the 
intervention 
received." 
0% attrition. Test 
products reported 
as well tolerated. 




























Low risk of bias Unclear High risk of bias Unclear Low risk of bias High risk of bias Unclear 




number table into 
either the BR 
group followed by 
the WR group 
(BR-WR, n 14) or 
the WR group 
followed by the 
BR group (WR-
BR, n 13)." 
No description of 
allocation 
concealment 







and may have 
been influenced. 




There appears to 




were both IG and 
CG reported 
identical follow-
up values for 





final value for CG 
was an error. CG 
and IG were not 
compared, and the 
cross-over groups 





reporting to favor 
IG as the waist 
circumference 
decreased further 
in CG than IG, 
but only the IG 





Rating Unclear Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Unclear 























No description of 
allocation 
concealment 
No description of 
allocation 
concealment 









trial that involved 
3 treatment 
groups (refined, 
wheat, and oat + 
wheat diets)" 
Largest attrition 
was from the 
controlled group. 
Only 1 participant 
withdrew due to 
the study; unclear 
which group they 
were in. 







Unclear Unclear High risk of bias Low risk of bias Low risk of bias Unclear Unclear 
Evidence As per Tighe 
2010 
As per Tighe 
2010 
As per Tighe 2010 As per Tighe 
2010 
















As per Tighe 
2010 
Rating Low risk of bias Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 

























assigned to the 
WG or RG group  
with the use of 
block random 
assignment with 
stratification by  
BMI (20–25, 25–
30, and 30–35), 
age (40–55 and 









had no contact 
with  
participants and 
had no role in the 
data collection, 
assigned the  
random-
assignment 
coding for the 
WG and RG 
groups."  
No description of 
allocation 
concealment 
No attempt at blinding Not blinded, but 
most outcomes 
were objective.  
Attrition was low 
(<15%) for both 
groups, and only 
one participant in 
each group 
withdrew due to 
reasons related to 
the study. No bias 
detected. 
None detected. None detected. 
Rating Low risk of bias Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Low risk of bias 






















e 2015 50 






assigned by the 
dietitian to the 
WG or the control 
group on the basis 
of a 
randomization 
sequence that was 
previously 
generated by the 
statistician with 















No description of 
allocation 
concealment 




have led to 
possible biases in 
psychological 
response and 











Attrition was low 
for both groups 
and none was 
related to the 
study. 
None detected. None detected. 
Rating Unclear Unclear High risk of bias Low risk of bias Low risk of bias Low risk of bias Unclear 























No description of 
randomization 
technique 
No description of 
allocation 
concealment 
No attempt at blinding "all the 
researchers not 














Attrition was low 
for both groups 
and none was 
related to the 
study. 







Table 5: Summary of outcomes reported by the 26 included randomized controlled trialsa 
which compare whole grain or whole pseudo-grain interventions and placebo or refined grain 







RCTs reporting significant 
improvements favoring whole 
grain 
RCTs reporting significant 
improvements favoring refined grain 
Inflammatory 
markers (10)  
n=21 CRPd n=2/5 (40%) 
hsCRPe n=1/11 (9%) 
ILf-β n=1/2 (50%) 
IL-6 n=1/9 (11%) 
TFNg-α n=1/6 (17%) 
PAIh-1 n=1/5 (20%) 
IL-8 n=0/2 (0%) 
IL-10 n=0/2 (0%) 
Adiponectin n=0/5 (0%) 
Leptin n=0/4 (0%) 
CRP n=0/5 (0%)  
hsCRP n=1/11 (9%)  
IL-β n=0/2 (0%)  
IL-6 n=0/9 (0%)  
TFN-α n=0/6 (0%)  
PAI-1 n=0/5 (0%)  
IL-8 n=0/2 (0%)  
IL-10 n=0/2 (0%)  
Adiponectin n=0/5 (0%)  




n=6 TBARSi n=1/2 (50%)  
GSH-Pxj n=1/1 (100%)  
FRAPk n=0/1 (0%)   
8-iso PGF2al n=0/4 (0%)  
ORACm n=0/1 (0%)  
SODn n=0/1 (0%)  
ADMAo n=0/1 (0%)  
TBARS n=0/2 (0%)  
GSH-Px n=0/1 (0%)  
FRAP n=0/1 (0%)   
8-iso PGF2a n=0/4 (0%)  
ORAC n=0/1 (0%)  
SOD n=0/1 (0%)  




n=19 HOMA-IR n=1/12 (8%)  
Postprandial plasma insulin n=2/5 
(40%)  
Fasting plasma glucose n=2/14 
(14%)  
Postprandial plasma glucose n=2/4 
(50%)  
Fasting plasma insulin n=0/14 (0%)  
HbA1c% n=0/9 (0%)  
HOMA-IR n=0/12 (0%)  
Postprandial plasma insulin n=0/5 (0%)  
 
Fasting plasma glucose n=0/14 (0%)  
 
Postprandial plasma glucose n=0/4 
(0%)  
Fasting plasma insulin n=0/14 (0%)  
HbA1c% n=0/9 (0%)  
Blood lipids (5) 
  
n=18 Total cholesterol n=3/16 (19%)  
LDLp cholesterol n=4/16 (25%)  
HDLq cholesterol n=2/17 (12%)  
Triglycerides n=2/17 (12%)  
VLDLr cholesterol n=0/1 (0%)  
Total cholesterol n=3/16 (19%)  
LDL cholesterol n=1/16 (6%)  
HDL cholesterol n=1/17 (6%)  
Triglycerides n=1/17 (6%)  
VLDL cholesterol n=0/1 (0%) 
Hemodynamics 
(4)  
n=12 Pulse pressures n=3/3 (100%)  
SBPt n=3/13 (23%)  
DBPu n=1/13 (8%)  
Mean arterial pressure n=0/1 (0%)  
Pulse pressurec n=3/3 (100%)  
SBP n=0/13 (0%)  
DBP n=1/13 (8%)  




n=2 Prediabetes incidence n=1/2 (50%)  
MetSw incidence n=0/2 (0%)  
Prediabetes incidence n=0/2 (0%)  




n=15 Total body weight n=2/13 (15%)  
Fat mass (kg)n=1/3 (0%)  
WCx n=2/12 (17%)  
BMIy n=0/9 (0%)  
Fat mass (%) n=0/4 (0%)  
FFMz (kgaa) n=0/4 (0%)  
Total body weight n=0/13 (0%)  
Fat mass (kg)n=0/3 (0%)  
WC n=1/12 (8%)  
BMI n=0/9 (0%)  
Fat mass (%) n=0/4 (0%)  
FFM (kg) n=0/4 (0%)  
a. RCTs which measured an outcome but did not compare groups were excluded from Table 3. Data included 
were from 25 unique RCTs which had 26 intervention arms, but were reported across 30 publications. 
b. Number of different outcomes reported within the outcome category 
c. Randomized controlled trial 
d. C-reactive protein 
e. high-sensitivity C-reactive protein 
f. Interleukin 
g, Tumor necrosis factor 
h. Plasminogen activator inhibitor 
i. Thiobarbituric acid reactive substances 
j. Glutathione peroxidase 
k. Total antioxidant capacity of plasma 
l. 8-iso-prostaglandin F2 alpha 
m. Oxygen radical absorbance capacity 
n. Superoxide dismutase 
o. Asymmetric dimethylarginine 
p. Low-density lipoprotein 
q. High-density lipoprotein 
r. Very low-density lipoprotein  
s. Although there was a significant difference between groups for this outcome it is not clear whether the changes 
favored intervention or control in any study as all values were within the normal range (i.e. between 40 and 
60mmHg), effect sizes were small, and/or data was only presented graphically. 
t. Systolic blood pressure 
u. Diastolic blood pressure 
v. Cardiovascular disease 
w. Metabolic syndrome 
x. Waist circumference 
y. Body mass index 
z. Fat free mass 
aa. Kilogram 
 
Table 6: Pooled effects and confidence in the body of evidence based on 20 randomized controlled trials (reported across n=22 publications) 
which compare whole grain or whole pseudo-grain interventions and placebo or refined grain controls in humans. 






SMDc (95%CId) Model I2 (%) p-value GRADE 
CRPe/hsCRP  14 658/644 -0.19 (-0.57, 0.20) REf 88.9 0.542 Moderateh 
ILg-6  9 458/432 -0.08 (-0.29, 0.13) RE 51.0 0.457 Moderate 
Fasting blood glucose  16 742/722 -0.01 (-0.19, 0.16) RE 60.4 0.875 Very low 
Fasting blood insulin  13 649/626 0.07 (-0.05, 0.18) RE 0 0.265 Moderate 
HOMA-IR  12 528/500 -0.03 (-0.17, 0.10) RE 0 0.603 Moderate 
HbA1c  10 404/403 -0.24 (-0.53, 0.06) RE 75.0 0.122 Moderate h 
Total cholesterol (Figure 3) 16 791/757 
 
-0.10 (-0.29, 0.09) RE 67.3 0.291 Very low h 
HDLi cholesterol 18 775/750 -0.0 (-0.03, 0.03) RE 38.7 0. 896 Lowj 
LDLk cholesterol (Figure 4) 15 783/751 -0.07 (-0.25, 0.10) RE 59.6 0.405 Very low h 
Triglycerides  16 753/727 -0.06 (-0.21, 0.10) RE 49.9 0.477 Very low h 
SBPl  11 482/481 -0.04 (-0.28, 0.21) RE 71.3 0.781 Very low 
DBPm  12 515/514 0.05 (-0.26, 0.37) RE 83.1 0.730 Very low 
Total body weightn 16 602/587 -0.02 (-0.24, 0.19) RE 70.8 0.826 Very low 
Waist circumference 14 641/625 -0.10 (-0.25, 0.05) RE 35.5 0.117 Moderate 
a. IG, intervention group 
b. CG, control group 
c. SMD, standardized mean difference  
d. CI, confidence intervals 
e. CRP, C-reactive protein;  
f. RE, random effects 
g. IL, interleukin  
h. GRADE assessment reflects confidence in the statistically significant subgroup rather than the overall analytical model. 
i. HDL, high density lipoprotein  
j. GRADE assessment reflects confidence in the statistically significant subgroup grain type: mixed, rather than the overall analytical model or the subgroup study 
quality: unclear 
k. LDL, low density lipoprotein  
l. SBP, systolic blood pressure  
m. DBP, diastolic blood pressure  
n. Weight change was meta-analyzed for total body weight change in preference to BMI as fewer studies reported BMI change. 
Table 7: GRADE evidence and summary of findings table: whole grains compared to refined grains for cardiovascular disease risk. 
Certainty assessment № of patients Effect 















CRPb/hs-CRP - Study quality (high) subgroup 





serious d,e not serious f not serious  none  311  360  SMDg 0.22 SDh 
lower 









serious e not serious f not serious  none  458  432  SMD 0.08 SD 
lower 





Fasting blood glucose 




very serious i not serious f not serious  none  742  722  SMD 0.01 SD 
lower 
(0.19 lower to 0.16 
higher)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Fasting blood insulin 




not serious  not serious f not serious j none  649  626  SMD 0.07 SD 
higher 










not serious  not serious f not serious  none  528  500  SMD 0.03 SD 
lower 





HbA1c - Study quality (high) subgroup 
Certainty assessment № of patients Effect 




















not serious d not serious f serious j none  97  97  SMD 0.33 SD 
lower 





Total cholesterol - Grain type (oats) subgroup 




very serious i,k not serious f serious j none  122  110  SMD 0.54 SD 
lower 
(0.95 lower to 0.12 
lower)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
HDL cholesterol - Grain type (mixed) subgroup 




not serious d not serious f not serious  none  292  298  SMD 0.17 SD 
lower 







HDL cholesterol - Study design (moderate) subgroup 




not serious d not serious f serious j none  255  235  SMD 0.33 SD 
higher 





LDL cholesterol - Grain type (oat) subgroup 




serious d, k  not serious f serious j none  122  110  SMD 0.57 SD 
lower 
(0.84 lower to 0.31 
higher)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Triglycerides - Grain type (rice) subgroup 
Certainty assessment № of patients Effect 




















serious d, k not serious f not serious  none  171  167  SMD 0.22 SD 
lower 
(0.44 lower to 0.01 
lower)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Systolic blood pressure 




very serious i not serious f not serious  none  482  481  SMD 0.04 SD 
lower 






VERY LOW  
IMPORTANT  
Diastolic blood pressure 




very serious i not serious f not serious  none  515  514  SMD 0.05 SD 
higher 
(0.26 lower to 0.37 
higher)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Total body weight 




very serious i not serious f not serious  none  602  587  SMD 0.02 SD 
lower 
(0.24 lower to 0.19 
higher)  
⨁◯◯◯ 
VERY LOW  
IMPORTANT  
Waist circumference 




not serious  not serious f not serious  none  641  625  SMD 0.1 SD lower 





a. CRP, c-reactive protein. 
b. CI, confidence intervals 
c. Some studies had unclear or high risk of bias  
d. Although the initial model had higher heterogeneity, this was explained by the subgroup analysis upon which this GRADE assessment is being performed.  
e. There was some statistical heterogeneity (I2 between 30 and 60%)  
f. Although this outcome is a risk factor for CVD, and does not directly represent CVD; all outcomes in this review are CVD risk factors and therefore the decision 
was made to not downgrade all markers on this basis. This measure was considered to be a direct measure of the risk factor.  
g. SMD, standardized mean difference 
h. SD, standard deviation 
i. There was high statistical heterogeneity (I2 between 60 and 100%)  
j. The upper or lower 95%CI crosses an effect size of 0.5 in either direction  
k. There is a risk of inconsistency due to there being fewer than 400 participants in this subgroup  
l. All studies have high or unclear risk of bias  
  
 
Table 8: Recommendations assessment and justification for the use of whole grains to improve cardiovascular disease risk using GRADE 
clinical recommendations for populations software on GRADEpro 
Problem 
Is the problem a priority? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 
○ No 
○ Probably no 
○ Probably yes 
● Yes 
○ Varies 
○ Don't know  
Ischemic heart disease and stroke, both forms of CVDa, are the top two causes of morbidity and death worldwide (WHO, Top 10 
Causes of death, https://www.who.int/).  
Qualitative research has shown significant impacts on the lived experience of people with CVD. Important themes include "living 
in the shadow of fear", "living a restricted life", and "battling the system" (Ryan and Farrelly, Euro J Cardiovas Nurs, 2009, 8:223-
231). 
Desirable Effects 
How substantial are the desirable anticipated effects? 






○ Don't know  
Based on the results of this systematic review: 
Of the 40 outcomes on which data were reported, 23 were found to have one or more RCTb report a beneficial effect of the 
intervention. There were 7 outcomes which reported any beneficial effect for the refined group.  
Pooled effects found some significant beneficial outcomes when investigating by subgroups (type of grain, study quality) for total 
cholesterol, LDLc cholesterol, triglycerides, CRPd, and HbA1c. Although most models were not significant, this shows there is a 
trend towards desirable effects on cardiovascular risk factors. However, despite statistical significance, effect sizes were small, with 
most having clinically insignificant effect sizes. When drawing upon other literature, such as the systematic reviews and meta-
analyses of observational studies which have reported a dose-response relationship between whole grain intake and reduced risk of 
CVD death (Aune et al, BMJ, 2016, 353; Wei et al, Br J Nutr, 2016, 116; Chen et al, Am J Clin Nutr, 2016, 3), the effects strongly 
favor the intervention. However, observational research has a lower level of evidence in the evidence hierarchy, as it is 
accompanied by confounding variables which are not properly or easily accounted for in multivariable models. Therefore, strong 
conclusions cannot be drawn in favor of the intervention.  
There was one pooled estimated effect which favored the refined grains, which was a decrease in HDLe cholesterol. However, the 
effect size was clinically insignificant. 
Other considerations are side-effects/adverse events. Four studies reported minor gastrointestinal symptoms (likely related to the 
intervention), which are of trivial consideration, and occurred in both groups. Other adverse events were unlikely to be related to the 
intervention.  
Undesirable Effects 
How substantial are the undesirable anticipated effects? 






○ Don't know  
Based on the results of this systematic review: 
Of the 40 outcomes on which data were reported, 23 were found to have one or more RCT report a beneficial effect of the 
intervention. There were only 7 outcomes which reported any beneficial effect for the refined group.  
Pooled effects found some significant beneficial outcomes when investigating by subgroups (type of grain, study quality) for total 
cholesterol, LDL cholesterol, triglycerides, CRP, and HbA1c. Although most models were not significant, this shows there is a 
trend towards desirable effects on cardiovascular risk factors. However, despite statistical significance, effect sizes were small, with 
most having clinically insignificant effect sizes. When drawing upon other literature, such as the systematic reviews and meta-
analyses of observational studies which have reported a dose-response relationship between whole grain intake and reduced risk of 
CVD death (Aune et al, BMJ, 2016, 353; Wei et al, Br J Nutr, 2016, 116; Chen et al, Am J Clin Nutr, 2016, 3), the effects strongly 
favor the intervention. However, observational research has a lower level of evidence in the evidence hierarchy, as it is 
accompanied by confounding variables which are not properly or easily accounted for in multivariable models. Therefore, still 
prevent strong conclusions being drawn in favor of the intervention.  
There was one pooled estimated effect which favored the refined grains, which was a decrease in HDL cholesterol. However, the 
effect size was clinically insignificant. 
Other considerations are side-effects/adverse events. Four studies reported minor gastrointestinal symptoms (likely related to the 
intervention), which are of trivial consideration, and occurred in both groups. Other adverse events were unlikely to be related to the 
intervention.  
Certainty of evidence 
What is the overall certainty of the evidence of effects? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 




○ No included studies 
The GRADE assessment of confidence in the body of evidence ranged from very low to moderate; looking across all outcomes, this 
was considered to be a low level of certainty in the evidence overall.  
  
Values 
Is there important uncertainty about or variability in how much people value the main outcomes? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION E 
○ Important uncertainty or variability 
○ Possibly important uncertainty or 
variability 
○ Probably no important uncertainty 
or variability 
● No important uncertainty or 
variability  
The outcomes of this review ranged from cardiovascular risk factors through to cardiovascular disease events and death. However, 
only data were found on cardiovascular risk factors. Although some biomarkers may be highly clinical in nature and not readily 
interpreted by patients; investigators considered there was no variability or uncertainty in the value of preventing cardiovascular 
disease (though the prevention/treatment of risk factors) by any stakeholder group: patients, clinicians, health services, 
governments, or industry. 
Qualitative research shows that individuals hold diverse values which must be interpreted through an appropriate cultural lens. 
Although values are diverse, commonality is the broad value for health and well-being (Davidson, Int J Nurs Stud, 2011, 11:1367-
1375). 
Balance of effects 
Does the balance between desirable and undesirable effects favor the intervention or the comparison? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 
○ Favors the comparison 
○ Probably favors the comparison 
○ Does not favor either the 
intervention or the comparison 
● Probably favors the intervention 
○ Favors the intervention 
○ Varies 
○ Don't know  
As described above, although beneficial and undesirable effects were reported by individual studies and in pooled estimates, the 
balance of effects favors the intervention. It should be noted that the effects are of marginal clinical significance, and therefore it is 
not possible to strongly conclude that the effects favor the intervention.  
This review has highlighted and discussed in detail the limitations in the existing body of interventional research which may explain 
such a finding. When interpreted alongside systematic reviews and meta-analyses of observational studies, which have reported a 
dose-response relationship between whole grain intake and reduced risk of CVD death (Aune et al, BMJ, 2016, 353; Wei et al, Br J 
Nutr, 2016, 116; Chen et al, Am J Clin Nutr, 2016, 3), the effects favor the intervention. However, observational research has a 
lower level of evidence in the evidence hierarchy, as it is accompanied by confounding variables which are not properly or easily 
accounted for in multivariable models. Therefore, still prevent strong conclusions being drawn in favor of the intervention.  
Resources required 
How large are the resource requirements (costs)? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 
○ Large costs 
○ Moderate costs 
● Negligible costs and savings 
○ Moderate savings 
○ Large savings 
○ Varies 
○ Don't know  
Grains are an affordable staple food, with whole grain sources available in the majority of countries, to all socioeconomic levels and 
geographical areas. Many countries and cultures also have locally grown and lesser known grains and pseudo-grains available for 
consumption (e.g. Khorasan wheat, teff). However, it must be acknowledged in small communities with limited access to the food 
supply, whole grain sources may not be a readily available alternative, but should be attainable by alternative methods such as bulk 
purchasing raw ingredients or products with long shelf-lives (e.g. brown rice, wholemeal flour). Availability of whole grains has 
also increased in recent years due to the impact of dietary guidelines on food policies and competition among food suppliers 
(Mancino et al, Food Policy, 2008, 33).  
No additional resources are required to implement the intervention as consuming whole grains simply replaces refined grains, and is 
therefore a negligible intervention for most communities/populations. A judgement of negligible costs and savings was made by the 
review authors, but it must be acknowledged that this may not be the case for some vulnerable groups.  
Certainty of evidence of required resources 
What is the certainty of the evidence of resource requirements (costs)? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 




○ No included studies 
Whilst the recommendation replaces one food (refined grains) with another (whole grains), it is acknowledged that there is some 
variation in the direct cost to consumers, with variation in the significance of this cost dependent of socioeconomic and 
geographical circumstances. 
Cost effectiveness 
Does the cost-effectiveness of the intervention favor the intervention or the comparison? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 
○ Favors the comparison 
○ Probably favors the comparison 
● Does not favor either the 
intervention or the comparison 
○ Probably favors the intervention 
○ Favors the intervention 
○ Varies 
○ No included studies  
Food basket studies have identified that whole grain products may be more expensive than refined grain alternatives. Although the 
cost difference is small to most families in developed countries, there could be a substantial cost to low income families (Jetter and 
Cassady, Am J Prevent Med, 2006, 30). Epidemiological research has further linked the varying cost of whole grains to variations 
in cholesterol levels, identifying that for every dollar of subsidies to whole grain products, that there is a medical cost savings of 
$13.2 (Rahkovsky and Gregory, Econ Hum Biol, 2013, 11).  
Population economic modelling using data from the UKf strongly advocates for any intervention which prevents CVD incidence, as 
even interventions with effect sizes of -1% incidence result in a cost saving of $48m/annum; and that dietary interventions are one 
of the most cost-effective approaches to achieve a reduction in incidence (Barton et al, BMJ, 2011, 343 and Brunner et al, Public 
Health Nutr, 2001). 
Despite this, due to this review finding that the evidence from RCTs (based on short intervention durations), show only trivial to 
small clinical significance, the authors felt that there is insufficient evidence to state that replacing refined grains with whole grains 
is cost-effective. This may change with further long term intervention studies which show a greater clinical impact. 
Equity 
What would be the impact on health equity? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 
○ Reduced 
○ Probably reduced 
○ Probably no impact 
● Probably increased 
○ Increased 
○ Varies 
○ Don't know 
The effect of the intervention is not dependent on sociocultural or socioeconomic circumstances. Baseline differences in 
socioeconomic groups would not results in a different effect. Many alternatives for CVD prevention and treatment have a higher 
cost and have greater barriers, such as medications or frequent health care consultations. Therefore, if effective, the choice of 
replacing refined grains with whole grains would increase access to CVD prevention strategies for vulnerable groups. The current 
review drew on literature from across Europe, the USAg, and Asia, finding that attrition was either equal between groups or higher 
in the control group, suggesting that whole grains were equally or better preferred across these diverse cultures. The current 
reviewers judged was that if effective and recommended to all populations, whole grains are an accessible, feasible, and acceptable 
intervention to help meet the disproportionate rise in CVD deaths amount low to middle-income countries (WHO, NCD mortality 
and morbidity, who.int).  
Acceptability 
Is the intervention acceptable to key stakeholders? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 
○ No 
○ Probably no 
○ Probably yes 
● Yes 
○ Varies 
○ Don't know 
Of clinical significance, the RCTs in this review reported that participants either had equal or lower attrition in the whole grain 
group, as well as a high compliance to the whole grain intervention when measured by plasma alkylresorcinol. This suggests that 
dietary intake of whole grains is a feasible dietary strategy in culturally diverse populations, and strengthens the need to test other 
types of grains that are important to certain cultural groups in RCTs.  
  
Feasibility 
Is the intervention feasible to implement? 
JUDGEMENT RESEARCH EVIDENCE & JUSTIFICATION 
○ No 
○ Probably no 
○ Probably yes 
● Yes 
○ Varies 
○ Don't know  
Of clinical significance, the RCTs in this review reported that participants either had equal or lower attrition in the whole grain 
group, as well as a high compliance to the whole grain intervention when measured by plasma alkylresorcinol. This suggests that 
dietary intake of whole grains is a feasible dietary strategy in culturally diverse populations and strengthens the need to test other 
types of grains that are important to certain cultural groups in RCTs.  
The strategy of promoting whole grains as opposed to refined grains may require high level strategic approaches from governments. 
For example, food subsidies (Rahkovsky and Gregory, Econ Hum Biol, 2013, 11), population policy interventions (Barton et al, 
BMJ, 2011, 343), and national dietary guidelines promoting whole grains (Mancino et al, Food Policy, 2008, 33) have demonstrated 
effectiveness and broad impact. From an individual point of view, whole grain consumption is in line with national dietary 
guidelines of many countries and is therefore already considered an important part of dietary recommendations made by health 
professionals and in public health strategies. 
a. CVD, cardiovascular disease 
b. RCT, randomized controlled trial 
c. LOL, low density lipoprotein 
d. CRP, c-reactive protein 
e. HDL, high density lipoprotein 
f. UK, United Kingdom 
g. United States of America 
  
 
